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Abstract 
The World Health Organization (WHO) declared tuberculosis (TB) to be a global health emergency in 
1993, and despite decades of extensive biomedical research, it remains a major cause of morbidity and 
mortality around the world. A disease primarily affecting the lungs, TB manifests following infection 
with a pathogenic member of the Mycobacterium tuberculosis (M. tb) Complex (MTBC) such as 
M. africanum and M. tb, although infection alone is not sufficient for disease. Each member of the
MTBC consists of several strains (or clades), with variable virulence and disease-causing mechanisms. 
M. africanum is the main cause of TB in West African countries including Ghana, while M. tb is
responsible for TB cases in most other parts of the world, with stratification of clades by geographical 
location. 
TB is a multifactorial disease, influenced by environmental factors, bacterial virulence, and the genetic 
susceptibility of the host. While the genetic susceptibility of the host to the tuberculous disease has 
been extensively studied using genome-wide association studies and candidate gene studies, no method 
currently exists to perform an association analysis between the genetic architecture of the host and the 
susceptibility to the many clades of M. tb or M. africanum causing disease. 
Two geographically distinct cohorts were included in this study: a cohort of 947 participants 
self-identifying as belonging to the five-way admixed South African Coloured (SAC) population with 
paired infecting M. tb isolate information was used to establish the protocol for performing the 
association analysis, while a second cohort consisting of 3 311 participants recruited in Ghana was 
used to validate this method. The method developed includes quality control filters on both the host 
genotype data, and the infecting isolate database. Thereafter, haplotype phasing and genotype 
imputation of several reference panels was performed to increase the number of single nucleotide 
polymorphisms (SNPs) available for association testing. An assessment of imputation quality scores 
revealed the best imputation reference panel for the study cohort and a multinomial logistic regression 
(MLR) analysis was performed to assess potential associations between host genotypes and infecting 
bacterial clades of multiple classes. 
Here, we demonstrated that the African Genome Resource (used via the Sanger Imputation Server) 
produced the highest quality of imputed genotype data for the SAC cohort, while the 1000 Genomes 
Phase 3 reference panel was the best reference panel for the Ghanaian cohort. MLR was performed 
while controlling for covariates including age, sex, and ancestry proportions. After genotype 
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imputation, 445 SAC - and 1 272 Ghanaian participants passed quality control and were tested for 
association to five- and six infecting superclades, respectively. Models of association revealed no SNPs 
reaching genome-wide significance for the SAC cohort, while 32 SNPs met the GWAS cut-off of 
5 x 10-8 for the Ghanaian cohort. For the Ghanaian cohort, the risk allele of SNP rs551641937 
(g.62385889G>A), located on chromosome 15, was determined to increase the risk of TB caused by 
the EAI/AFRI superclade by 276 times, when compared to the LAMCAM reference superclade. The 
emphasis of the dissertation was to perform an association analysis using host genotype and pathogen 
data and finding the best reference panel for imputing each of the two datasets was a secondary aim. 
This study demonstrates the first method successfully testing host-genotype associations with multiple 
clades of M. tb isolates causing disease.
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Opsomming 
Tuberkulose (TB) is in 1993 as 'n globale gesondheidsprobleem deur die Wêreld 
Gesondheidsorganisasie verklaar. Ondanks dekades se omvattende biomediese navorsing, bly TB 'n 
hoofoorsaak van sterftes wêreldwyd. TB is 'n siekte wat hoofsaaklik die longe affekteer en manifesteer 
na infeksie met 'n patogeniese lid van die Mycobacterium tuberculosis-kompleks (MTBK), naamlik 
M. africanum en M. tb. Elke lid van die MTBK bestaan uit verskeie stamme (of klade) wat verskil in 
virulensie. M. africanum is die hoofoorsaak van TB in lande in Wes-Afrika insluitend Ghana, terwyl 
Mycobacterium tuberculosis (M. tb) verantwoordelik is vir TB gevalle in die meeste ander dele van 
die wêreld, met klades wat gegroepeer kan word volgens hulle geografiese ligging. 
 
TB is 'n komplekse siekte met verskeie faktore wat dit beïnvloed, insluitend omgewingsfaktore, 
bakteriële virulensie en die genetiese vatbaarheid van die gasheer. Verskeie studies, insluitend 
genoom-wye assosiasie studies (GWAS) en kandidaat studies, is al uitgevoer om die genetiese 
vatbaarheid van die gasheer vir TB te ondersoek. Tot dusver is daar geen metode om assosiasies te 
analiseer tussen die genetiese struktuur van die gasheer en die vatbaarheid tot enige van die verskeie 
klades van M. tb of M. africanum.  
 
Die studie het gebruik gemaak van twee kohorte in verskillende geografiese areas: 'n groep van 947 
deelnemers wat hulself geïdentifiseer het as deel van die Suid Afrikaanse Kleurling (SAK) populasie, 
en 'n tweede groep met 3 311 deelnemers vanaf Ghana. Die SAK groep, afkomstig van vyf 
voorvaderlike populasies, met ooreenstemmende M. tb isolaat informasie was gebruik om die protokol 
vir gasheer genotipe-tot-infeksie klade te ontwikkel. 'n Tweede groep vanaf Ghana was ingesluit om 
die metode te valideer. Die metode sluit kwaliteitskontrole filters in vir beide die gasheer genotipe 
data, asook vir die infeksie isolaat databasis. Die volgende stap was haplotipe fasering en genotipe 
imputasie. Dit was uitgevoer met verskeie verwysings panele om die hoeveelheid enkel-nukleotied 
polimorfismes (ENP) beskikbaar vir assosiasie toetse te vermeerder. Die kwaliteit van imputasie was 
bepaal deur die beste verwysing paneel elke kohort te kieswaarna multinomiale logistieke regressie 
(MLR) analiese gebruik was om potensiale assosiasies tussen die gasheer genotipe en infekterende 
bakteriële klades van veelvuldige klasse te bepaal. 
 
Hierdie studie demonstreer dat die Afrika Genoom Hulpbron (gebruik deur die Sanger Imputasie 
Bediener) die beste kwaliteit imputasies gegee het vir genotipe data vir die SAK populasie, terwyl die 
1000 Genome Fase 3 verwysings paneel die beste was vir die Ghana kohort. MLR analise het 
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ouderdom, geslag en genetiese afkoms in ag geneem. Na genotipe imputasie, het 445 SAK en 1 272 
Ghana deelnemers die kwaliteits kontrole stappe geslaag en is afsonderlik getoets vir moontlike 
assosiasies met vyf of ses infekterende superklades, onderskeidelik. Die modelle van assosiasie het nie 
enige ENP in die SAK populasie uitgelig wat genoom-wyd statisties betekenisvol was nie, maar daar 
was egter 32 ENP’s wat 'n waarskynlikheids waarde kleiner as 5 x 10-8 gehad het vir die Ghana kohort. 
Daar is gevind dat een van die ENKs, rs551641937 (g.62385889G>A) geleë op kromosoom 15, die 
risiko van TB in verband met die EAI/AFRI super-klade 276 keer verhoog in vergelyking met die 
LAMCAM super-klade. Die klem van die verhandeling was om 'n assosiasie-analise uit te voer met 
behulp van gasheergenotipe en patogeen data en die vind van die beste verwysingspaneel om elkeen 
van die twee datastelle toe te pas, was 'n sekondêre doelwit. Hierdie studie demonstreer die eerste 
metode wat suksesvol gebruik was om te toets vir assosiasies tussen gasheer genotipe en veelvuldige 
klades wat TB veroorsaak. 
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CHAPTER ONE 
1. Introduction 
1.1. Background 
The World Health Organization (WHO) declared tuberculosis (TB) to be a global health emergency 
in 1993, and despite decades of extensive biomedical research, it remains a major cause of morbidity 
and mortality around the world (WHO 2017b). A disease primarily affecting the lungs, TB manifests 
following infection with a pathogenic member of the Mycobacterium tuberculosis (M. tb) Complex 
(MTBC). The MTBC consists of five species of mycobacteria, namely M. africanum, M. canetti, and 
M. tb (all pathogenic in humans), M. microti, a pathogen affecting mainly rodents, and M. bovis, which 
has adapted to cause disease in both humans and animals (Frothingham 1995). 
 
In this dissertation, reference will be made to clades which can be defined as the name given to a family 
of strains. For example, the modern Lineage 2 consists of the Beijing clade determined by means of a 
defined spoligotyping pattern. The Beijing clade, however, consists of numerous strains. The term 
‘clade’ may also be used interchangeably with ‘sub-lineage’, albeit that the latter term is commonly 
used in reference to numeric annotations of sub-members (Coll et al. 2014). The term “superclades” is 
used to describe the grouping of clades using a SNP-based phylogenetic tree. 
 
To date, several M. tb clades (Beijing, Haarlem, etc.) have been described and classified as belonging 
to one of seven MTBC lineages (Blouin et al. 2012). While the two clades of M. africanum, namely 
West African-1 and West African-2, are localised to Ghana and surrounding West African countries, 
there is a distinct spread of the seven M. tb lineages around the world (Gagneux et al. 2006; Chihota 
et al. 2018). Despite being derived from a common mycobacterial ancestor, different members of M. tb 
have been shown to cause a range of clinical symptoms and may exhibit varying responses to drug 
therapy (Gutierrez et al. 2005; van der Spuy et al. 2009). The response of the human host to infection 
with M. tb is also known to vary greatly and may be attributed to genetic susceptibility factors of the 
host (Brosch et al. 2002; Coscolla and Gagneux 2010). 
 
TB is a complex disease and despite many genetic studies aiming to identify susceptibility genes for 
TB, these investigations have had limited success and the factors predisposing to the disease remain 
largely unknown. Furthermore, outcomes of infection with a member of the MTBC depends on a 
number of factors, including the virulence of the bacterium, environmental conditions, and the 
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susceptibility of the host to developing the disease. Numerous studies have investigated the 
associations between the host genotypes and TB, as a disease of interest (Herb et al. 2007; Thye et al. 
2010; Bellamy et al. 1998). To this end, a number of host genetic factors have been identified to 
modulate susceptibility to the disease. However, to the limit of our current knowledge, no studies have 
been conducted to investigate the potential genome-wide associations between human genotypes and 
different members of the MTBC. 
 
Following diagnosis with active TB, patients are admitted to a standard treatment program consisting 
of four first-line drugs (Isoniazid (INH), Rifampicin (RIF), Ethambutol (ETB), and Pyrazinamide 
(PZA)) taken daily for two months, followed by a four-month treatment with RIF and INH. To reduce 
the chances of further transmission of M. tb, treatment is started as soon as a case of TB is confirmed 
in adults. However, this is usually initiated prior to any drug-susceptibility testing, or genotyping of 
the infecting strain. This clinical practice, along with incorrect prescription of anti-TB drugs and 
patient non-compliance has led to the development of numerous multi-drug resistant, and 
extensively-drug resistant TB strains (Cohen and Murray 2004). In recent years, host-directed 
therapies (HDT) have been proposed as an adjunctive to traditional antimycobacterial therapy. In 
contrast to antimicrobials, which directly target the pathogen, HDTs aim to target the host’s immune 
system in an effort to curb the progression of the disease, thereby avoiding the development of 
resistance to antimycobacterial drugs. 
 
Different members of the MTBC have shown to dominate different regions of the world, and 
simultaneously have varying degrees of virulence affecting their ability to cause disease in humans 
(Gagneux 2012). However, geographical separation of the MTBC lineages are potentially also being 
driven by population-specific host-genetic factors influencing susceptibility to infection. Thoroughly 
understanding the genetic factors within the host driving M. tb strain diversity within a study 
population may offer insight into the disease mechanisms, and possibilities for host-directed therapies 
to combat the epidemic. 
 
1.2. Problem identification 
Numerous studies have reported a role for host genetic components in susceptibility to TB (Bellamy 
1998; Moller and Hoal 2010; Kinnear et al. 2017). These predisposing genetic factors may explain 
why only a small proportion of immunocompetent individuals who have been infected with M. tb 
progress to develop active disease (Bloom and Murray 1992). In addition to this, investigations of host 
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genetic factors involved in susceptibility to different strains of M. tb have recently gained traction 
(Salie et al. 2014; Kamgue Sidze et al. 2013; Intemann et al. 2009; Brown et al. 2010). Therefore, it is 
tempting to speculate that if certain genetic markers conferring susceptibility to particular M. tb strains 
are common within a given population, this may in part explain the variable success rate amongst 
different strains within the community (Hanekom et al. 2007).  
 
Most studies investigating strain-specific genetic susceptibility to TB have used candidate gene study 
designs, while one recent study has used a genome-wide association analysis of susceptibility to 
different TB strains (Omae et al. 2017). In order to improve our understanding of the genetic 
susceptibility to TB clades, this study leveraged genome-wide genotyping data from the host and 
pathogen data to perform a genome-wide screen for M. tb clade-specific genetic associations in cohorts 
originating from two distinct populations. 
 
1.3. Aims 
The aim of this project was to investigate the association(s) between host genetic factors and the M. tb 
clade infecting the study participants. 
 
1.4. Objectives 
The objectives of the study were to: 
1. Develop a method for performing a genotype-to-strain association analysis using the South African 
dataset as a test cohort as follows: 
1.1. Match genotyped study participants to their infecting M. tb isolates  
1.2. Define M. tb clade and superclade groupings using a SNP-based phylogenetic tree 
1.3. Perform a preliminary assessment using PCA 
1.4. Obtain high-quality imputed genotype data through testing of multiple reference panels on the 
study dataset 
1.5. Perform an association analysis using high-quality imputed host genotype data and M. tb data 
2. Replicate the method on a second dataset, namely a dataset from Ghana 
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CHAPTER TWO 
2. Literature Review 
2.1. Prevalence 
As the ninth leading cause of death, and the leading cause of death by an infectious disease, 
TB remains a global health concern, outranking death caused by HIV/AIDS alone 
(WHO 2017b). According to the 2016 WHO TB report, 10.4 million incidence cases of TB 
were recorded worldwide of which 90% of those infected were adults, and 65% were male 
(WHO 2017b). Despite advancements in TB control and treatment, an increase of 200 000 TB 
cases from the previous year was reported globally, along with an estimated 1.3 million deaths 
due to TB amongst HIV-negative individuals (WHO 2017b). Since the current study focusses 
on two independent cohorts from South Africa and Ghana, the paragraphs to follow will 
describe the TB epidemics in both countries. 
 
In South Africa, TB remains a serious health concern, with the 2015 WHO report ranking South 
Africa sixth out of 22 high-burden countries. For most high-burden countries, the TB incidence 
rates range between 150 and 300 cases per 100 000 individuals annually. However, in 2014, 
South Africa saw a rate of more than 500 TB cases per 100 000 individuals, ranking second in 
incidence after Mozambique (WHO 2014a). The 2017 WHO TB country profile reported a 
marked decline in TB incidence for South Africa for 2016 (Table 1). 
 
Table 1: Statistics for South Africa, and Ghana for the 2016 reporting year 
 South Africa Ghana 
Population (in millions) 56 28 
TB Incidence  180 000 34 000 
Mortality (excludes HIV+TB) 23 000 10 000 
New MDR cases 3.4% 1.5% 
Reference WHO 2017c WHO 2017a 
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2.2. Socioeconomic and environmental risk factors 
The increasing rates of TB globally can be attributed to a number of factors (Figure 1). Since 
the emergence of HIV/AIDs, the health sector has been burdened by a marked increase in TB 
incidence (Bloom and Murray 1992). Other co-morbidities increasing risk for developing 
active TB include diabetes (Jiménez-Corona et al. 2013; Prada-Medina et al. 2017; Restrepo et 
al. 2018) and autoimmune diseases such as rheumatoid arthritis (Gómez-Reino et al. 2003; Lim 
et al. 2017), liver cirrhosis (Lin et al. 2014), and cancer with some forms of the disease 
increasing the risk of developing active TB nine-fold (Cheng et al. 2016). 
 
High humidity, poor house ventilation, and close contact with active TB patients have also 
been associated with increased risk of developing the active form of the disease (Pratiwi 2016; 
Seddon et al. 2013). Individuals living in highly-populated communities such as nursing homes 
(Stead et al. 1990), shelters, and jails (Coker et al. 2006) have also been shown to be at 
increased risk for contracting M. tb. Smoking, diabetes, and nutritional status are also known 
risk factors for developing the disease (Ramaliba et al. 2017; Cegielski et al. 2012). Low body 
mass index (BMI), reduced subcutaneous fat tissue, or low skeletal muscle volume have been 
reported to increase TB risk in individuals with normal nutritional status (Cegielski et al. 2012). 
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Figure 1: Risk factors driving the TB epidemic (adapted from Lönnroth et al. (2009)) 
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2.3. Transmission, acquisition, and response of the human host to infection 
TB is an airborne disease transmitted when aerosolised droplets containing the infectious M. tb 
bacillus are expelled from an infected person through coughing or sneezing and inhaled by an 
uninfected individual. Between one and 200 M. tb bacilli have been shown to cause disease in 
an exposed individual (Sakamoto 2012). However, as few as 10 bacilli have been shown to 
cause an infection in previously unexposed individuals (Behr et al. 1999). As a non-motile 
bacterium, M. tb requires a suitable host for successful transmission. To this end, M. tb has 
been hypothesised to have co-evolved with humans over thousands of years and as such, 
humans have become the ideal host (Comas et al. 2013; Hoal et al. 2017). 
 
The response of the human immune system to infection with M. tb is highly variable, 
influenced by numerous factors including the presence of pre-existing infections, the virulence 
of the bacterium, environmental and host genetic factors. Macrophages are immune cells 
central to the protective response of the host against foreign pathogens such as bacteria, fungi, 
and viruses. Following inhalation of M. tb into the lungs, pattern recognition receptors such as 
toll-like receptors (TLR) present on the cell surface of alveolar macrophages recognise and 
target the M. tb for a process of degradation known as phagocytosis (Thoma-Uszynski 2001). 
The combined efforts of these inflammatory molecules and immune cells results in the 
successful phagocytosis of the bacteria and formation of a well-organised collection of immune 
cells and degrading bacteria known as the granuloma (Davis and Ramakrishnan 2009).  
 
The containment of the bacteria within the macrophage elicits the activation and release of 
various proinflammatory cytokines such as interferon-gamma (IFN-), and several forms of 
tumour-necrosis factor (TNF), further promoting the recruitment of leukocytes, monocytes, 
and neutrophils to the site of infection. Dendritic cells, like macrophages, play crucial roles in 
immunity against TB, and following the phagocytosis of M. tb, migrate to regional lymph 
nodes to promote the recruitment of lymphocytes to the site of infection, and the subsequent 
release of IFN- (Stein et al. 2003). This cytokine promotes the induction of the autophagy 
process in which the M. tb-containing macrophage is targeted for degradation by means of p47 
GTPase activity (Gutierrez et al. 2004). 
 
The formation of the granuloma is beneficial to both the host and the bacterium. For the host, 
the granuloma signifies the successful capture of a pathogen. The bacteria, however, also find 
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the granuloma to be a safe location as they are protected from the pro-inflammatory cytokine, 
IFN- (Sakamoto 2012). Subsequent to engulfing a foreign organism, the macrophage forms a 
phagosome, which is able to fuse with the lysosome, creating an acidic phagolysosome that 
facilitates the degradation of the pathogen. However, M. tb are able to modify this acidification 
process by interfering with the production of the vacuolar proton ATPase and subsequently are 
able to survive within the phagosome before escaping into the cytosol for rapid replication 
(Sturgill-Koszycki et al. 1994). The relationship between M. tb and the human host is complex, 
seen as a complicated game of tug-of-war and co-evolution (Brites and Gagneux 2015; Comas 
et al. 2013; Hoal et al. 2017). 
 
2.4. Clinical presentation, Diagnosis and Treatment of TB 
In 1993, the WHO declared TB to be a Global Emergency and in September 2000, included 
TB treatment strategies as a global health priority in the Millennium Development Goals 
(WHO 2014b). Since then, extensive TB research has led to the development of numerous 
treatments, resulting in the decline of TB incidence in many developed countries. 
 
The clinical manifestation of M. tb infection can be classified by its anatomical involvement as 
either pulmonary TB, with primary involvement of the lungs, or as extrapulmonary TB, which 
manifests in various organs and tissues outside of the lung, including the brain, gastrointestinal 
tract, lymph nodes, skin, and joints (WHO 2013). TB is also classified according to the disease 
state of the host as either active TB, or latent TB infection, described in more detail below (Al-
Orainey 2009). 
 
The Bacille Calmette-Guérin (BCG) vaccine was developed between 1906 and 1919 through 
numerous rounds of passaging of M. bovis on a growth surface consisting of ox-bile and potato 
slices soaked in glycerol (Sakamoto 2012). However, despite the widespread use of the BCG 
vaccine in children, TB incidence has continued to increase in many developing countries 
(WHO 2017b). Although BCG is commonly used to prevent TB in children, it has been 
unreliable in preventing disease in adults (Brosch et al. 2007). 
 
 Latent TB 
After infection with M. tb, the majority of individuals will remain asymptomatic and contain 
the bacterium, and enter a stage termed latent TB infection (LTBI). These individuals do not 
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exhibit the clinical symptoms of the disease due to the mycobacteria not being in an actively 
replicating state, but remain at risk for developing the disease through endogenous reactivation 
(Vynnycky and Fine 2000). This large reservoir of individuals harbouring “dormant” 
mycobacteria have been hypothesised to, with sudden sufficient immunosuppression, become 
a significant source for active TB cases (Lin and Flynn 2010). 
 
LTBI is at present inferred from measures of acquired anti-mycobacterial immunity, such as a 
tuberculin skin test (TST) and/or interferon gamma release assay (IGRA). The TST (also 
known as the Mantoux test) is used to test for exposure to M. tb antigens. An intracutaneous 
injection of 0.1 ml of tuberculin is administered, followed by visual inspection and the 
measurement of induration by a clinician (Ayub et al. 2004; Nayak and Acharjya 2012). This 
visual measurement of induration is highly subjective, leading to large margins of error, 
variability in the interpretation and can result in both false-positive and false-negative 
diagnosis. False-positive results have been identified in patients with previous exposure to 
non-tuberculous mycobacteria as well as individuals with prior vaccination with BCG, 
particularly when administered for the first time at school-going age, or as multiple booster 
shots (Farhat et al. 2006). 
 
The IGRA is an in vitro assay, used to quantitatively evaluate the response of the host’s 
cell-mediated immunity to M. tb bacilli. Although useful in confirming the results of a TST, 
the IGRA, like the TST, cannot differentiate between latent infection with M. tb and reactivity 
due to vaccination with BCG (Mandalakas et al. 2008). However, unlike the TST, an IGRA 
assay does not require a follow-up assessment, and has demonstrated a high degree of 
specificity in regions experiencing low TB incidence (Sester et al. 2011). Two commercially 
available IGRAs are the QuantiFERON®-TB Gold In-Tube (QFT) assay, and the T-SPOT.TB 
assay. Both of these assays are enzyme-linked immunosorbent assay (ELISA)-based and use 
the mycobacterial antigens, early secretory antigenic target 6kD (ESAT-6) and culture filtrate 
proteins (CFP-10), to induce an immunological reaction (Horvat 2015). While the 
QuantiFERON® assay directly measures the amount of IFN- produced, the T-SPOT.TB assay 
measures the number of IFN--producing T-cells. (Pai et al. 2014). 
In low incidence countries such as the United States, the decision to test for latent TB is 
preceded by the decision to treat if the test outcome is positive (Schluger and Burzynski 2010). 
However, this approach is not highly favoured as it comes coupled with social consequences 
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such as stigma (Daftary et al. 2017), effects on health due to administering of anti-TB drugs 
with unfavourable side-effects, and a financial strain on both the patient and the health sector 
(van’t Hoog et al. 2014). Owing to the high cost of screening a large proportion of the 
population for a low yield of patients requiring TB treatment, most countries have taken the 
decision to only screen for TB in high-risk individuals, preventing a generalised treatment for 
latent TB infection (van’t Hoog et al. 2014). However, the risk for initiating an outbreak of 
active TB as harboured by latently infected individuals may be considered sufficient to justify 
testing individuals with latent TB residing in a high-burden setting. By treating individuals 
latently infected with M. tb, the number of active TB cases may be minimised and the epidemic 
curbed (Lin and Flynn 2010). 
 
 Active TB 
Active pulmonary TB is diagnosed in patients presenting with symptoms of infection with 
M. tb which include fever, a persistent cough, and significant weight loss, as well as being 
culture-positive for the M. tb bacteria, while patients with latent TB do not have any clinical 
signs of the disease (Cohen et al. 1996). Diagnosis of active TB can generally be placed into 
three categories: 1) Radiological methods, 2) Smear microscopy and culture, and 3) Molecular 
methods. Radiological examination may be conducted using the standard chest X-ray or chest 
computed tomography. Both technologies are able to provide a visual assessment of internal 
lung structures, but are insufficient as a sole means of diagnosing active TB due to the chest 
X-ray being able to visualise cavitary lesions in some, but not all patients with active TB (Krysl 
et al. 1994). Thus, active TB still needs to be confirmed through examination of a sputum 
sample for the presence of M. tb bacilli.  
 
Sputum smear microscopy is the most widely-used and accessible method for the detection of 
M. tb in patients suspected of having TB. However, this method requires the patient to be 
present at the healthcare facility over several consecutive days to provide the multiple sputum 
samples needed for testing, and is thus a costly and inconvenient way of being tested for TB 
(Parsons et al. 2011). To obtain a sample for staining, individuals suspected of having active 
TB are required to produce sufficient sputum for staining of the acid-fast bacilli (AFB) using 
Ziehl-Neelsen staining (Ryu 2015). This has been hard to achieve in children, and HIV-positive 
individuals, as they do not usually produce a sufficient sample and even when more invasive 
methods such as bronchoalveolar lavage (BAL) or gastric aspiration, are used, 95% of cases in 
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children were AFB smear-negative, and the diagnosis inconclusive (Starke and Taylor-Watts 
1989). 
 
Although direct examination of sputum samples using microscopy techniques is useful for 
identifying the presence of M. tb, the method is unable to differentiate between 
drug-susceptible and drug-resistant strains. To achieve this, M. tb can be cultured on various 
forms of culture media, such as Lowenstein-Jensen (LJ) media in the solid, slant, or broth form. 
On solid media, culturing of M. tb can take between two to four weeks for samples that were 
M. tb positive during microscopic examination, while microscopy-negative sputum samples 
may take up to two months for successful culture of the bacterium (Ryu 2015). This lengthy 
time for culture drastically impedes rapid diagnosis of patients with active TB, delaying 
treatment and enabling the transmission of the pathogen during a highly infectious stage. The 
culturing of M. tb on LJ media is however no longer common practise, and has been replaced 
with the mycobacterium growth indicator tube (MGIT) system which detects the growth of 
mycobacteria in culture via fluorescence of an oxygen sensor (Tortoli et al. 1999).  
 
Lastly, three molecular methods are commercially available for TB testing. Nucleic acid 
amplification (NAA) is able to detect the presence of M. tb weeks before a diagnosis is 
confirmed by culture. Despite its rapidity, currently used NAA tests are not recommended in 
cases where evidence for TB is low as the positive predictive value for the test has been shown 
to be less than 50% in such cases (American Thoracic Society 2000). The line probe assay 
(LPA) is another molecular diagnostic technique which rapidly tests for drug susceptibility in 
M. tb (WHO 2008). The test assesses the potential survival of the bacterium in response to two 
first-line anti-TB drugs, INH and RIF, by testing for the presence of a wild type or mutant allele 
which confer these drug-resistance capabilities. The GeneXpert MTB/RIF Ultra assay 
developed by Cepheid is an automated NAA test (WHO 2013). The cartridge-based assay is 
able to offer a TB diagnosis, as well as RIF resistance status, as early as two hours after sample 
collection. A benefit that this technique offers over all others is that the GeneXpert cartridges 
are preloaded with all the reagents necessary for the assay, thus requiring very little hands-on 
time, and subsequently optimising TB diagnosis (WHO 2013). 
 
Four first-line TB drugs currently in use are EMB, INH, PZA, and RIF. The TB treatment 
strategy consists of a two-month schedule consisting of all four drugs, followed by four months 
treatment with RIF and INH (WHO 2013). To prevent the emergence of new 
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antimicrobial-resistant strains, patients are required to diligently complete the treatment 
regimen consisting of the four drugs taken daily for a period of six to nine months. Though 
effective in curbing the emergence of MDR- and extensively drug-resistant (XDR) strains, the 
chemotherapeutic nature of the drugs has been shown to be toxic to patients, perhaps 
contributing to a decrease in patient compliance (Gülbay et al. 2006). 
 
Patients presenting with microbial resistance to INH and RIF are classified as MDR and may 
need up to two years of treatment with fluoroquinolones and aminoglycosides to completely 
eradicate M. tb. Resistance to first-line anti-TB drugs, fluoroquinolones, and aminoglycosides 
in patients is classified as XDR cases and requires treatment with drugs that are much more 
expensive than first- and second-line drugs, have shown to produce more negative side-effects, 
and have been associated with more instances of poor patient outcomes (Pietersen et al. 2014). 
Total drug resistant (TDR) strains of M. tb are identified by resistance to all first-line and 
second-line anti-TB drugs and have been confirmed in Iran, India, and South Africa (Migliori 
et al. 2007; Udwadia et al. 2012; Velayati et al. 2009; Klopper et al. 2013). In 2013, a study 
identified several patients infected with an atypical Beijing genotype clone in South Africa, 
notably developing resistance to all first-line drugs, fluoroquinolones, and aminoglycosides, 
amongst other second-line drug therapies (Klopper et al. 2013). This observation is of 
particular significance due to South Africa experiencing a high burden of TB caused by 
members of the Beijing genotype (van der Spuy et al. 2009; Chihota et al. 2018). 
 
2.5. Genetics of TB susceptibility 
 Studies investigating genetic susceptibility to TB 
In addition to socio-economic and environmental factors, and the presence of predisposing 
diseases, the genetic make-up of the human host has also been shown to play a significant role 
in determining susceptibility to a disease. Numerous studies have unequivocally shown 
associations between genomic loci and susceptibility to infectious diseases such as malaria 
(Rockett et al. 2014), HIV (Pastinen et al. 1998) and TB (Herb et al. 2007; Thye et al. 2010; 
Bellamy et al. 1998).  
Some of the earliest events alluding to a human genetic contribution to TB susceptibility were 
tragic events in history and claimed many lives. The Qu’Appelle population of the 
Sasketchewan province in Canada were heavily impacted following their first exposure to M. tb 
which resulted in an annual loss of up to 10% of the population (Motulsky 1960). During the 
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first three generations following the arrival of the bacterium to the community, more than half 
of the families had succumbed to the disease. After this initial period during which most of the 
susceptible individuals had died, the annual death rate as caused by TB was reduced to 0.2%, 
possibly owing to a selection against the susceptibility genes for TB within the population 
(Motulsky 1960).  
 
The Lübeck disaster was another tragic event which provided early evidence for genetic 
components playing a role in susceptibility to M. tb infection. Instead of receiving the 
attenuated strain for vaccination, a total of 252 infants were accidentally injected with a BCG 
vaccine contaminated with virulent M. tb. The infants displayed variable responses to the 
bacterium where 108 of the infants had signs of TB and survived, while 67 infants died as a 
result of developing active TB (Rieder 2003; “The Lübeck Catastrophe: A General Review” 
1931). Besides the possibility of genetic components being responsible for the variable 
response to infection with M. tb, the vaccine vials administered to the infants also contained 
variable dosages of the infectious bacterium. This became evident when infants receiving lower 
dosages of the bacterium were recorded to have a wide range of clinical phenotypes, while 
those who received a higher dosage were highly susceptible to developing TB, indicating the 
apparent ability of the innate immune system to control infection caused by low doses of M. tb 
(Fox et al. 2016).  
 
Early studies involving twins provided evidence for genetic components modulating 
susceptibility to TB. A higher degree of concordance for disease was found in monozygotic 
twins compared to dizygotic twins (Kallmann and Reisner 1943). Although these observations 
were substantiated during a reanalysis of the Prophit study (Comstock 1978), this study did not 
consider the possible confounding effects of environmental factors. Thus, results from a 
comparison of hereditary factors with environmental factors concluded that environmental 
factors such as the number of bacilli during transmission were of more significance than genetic 
factors of the host in determining progression to disease (van der Eijk et al. 2007). 
 
Numerous studies have proceeded to investigate the risk of disease amongst individuals living 
in close proximity to TB patients. An early observation of TB in families reported that 
individuals who were spouses to TB patients, and came from a family with a history of TB 
themselves, were at increased risk for developing the disease than spouses with no family 
history of TB (Puffer 1944). Another study of TB cases in a nursing home in the USA revealed 
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that individuals with African ancestry were more likely than those of European ancestry to be 
infected with M. tb, even when they were living in the same environment ((Stead et al. 1990) 
as reviewed in (Kinnear et al. 2017)).  
 
A number of approaches have been used to investigate the observed differences in the genetic 
susceptibility of the human host to M. tb. These include genome-wide linkage analyses, 
candidate-gene association studies, and genome-wide association studies, and will be discussed 
in the paragraphs to follow (reviewed in (Möller et al. 2010; Abel et al. 2017; Kinnear et al. 
2017)). 
 
 Whole-Genome Linkage Studies 
Linkage studies interrogating the whole genome aim to trace the inheritance of chromosomal 
regions harbouring putative susceptibility genes and have proven to be highly successful when 
examining monogenic diseases (Ferreira 2004), while associations found for complex diseases 
such as TB have been difficult to replicate (reviewed in (Altmüller et al. 2001)). In a TB linkage 
study conducted by Jamieson and colleagues, four genes located on chromosome 17q showed 
individual effects associated with modifying susceptibility to TB in a cohort of Brazilian 
patients (Jamieson et al. 2004). Another study conducted on an extended Aboriginal Canadian 
family of 81 members reported linkage between a TB-susceptibility locus and D2S424, a gene 
in close proximity to the natural resistance associated macrophage protein-coding gene 
(NRAMP1), while there was no association with the human leukocyte antigen (HLA) class of 
genes - a complex well-known to play a role in the progression of TB (Greenwood et al. 2000). 
 
A genome-wide linkage analysis of 92 sibling-pairs from The Gambia and South Africa 
revealed suggestive evidence of linkage to loci on 15q and Xq, and TB (Bellamy et al. 2000). 
A linkage study conducted in a Ugandan population identified chromosomal regions 2q21, 
2q24, 5p13, and 5q22 as being associated with TST negativity (Stein et al. 2008), while in a 
South African cohort, reactivity to the TST test was linked to the TST1 chromosomal region 
11p14 and TST2 located on chromosome 5p15 (Cobat et al. 2009), and was replicated in a 
French cohort (Cobat et al. 2015). Two loci on chromosomes 3q and 8q were associated with 
modulating the production of IFN- via the ESAT-6 pathway (Jabot-Hanin et al. 2016), while 
in a Peruvian population, variants on chromosome 3q23 were shown to be associated with early 
progression to active TB (Luo et al. 2018). 
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 Candidate-gene studies 
Early candidate-gene association studies have been successful in providing new clues to TB 
susceptibility as the study design allows for the investigation of associations between genes 
pre-selected on the basis of their biological importance to disease mechanisms, as well as to 
the disease of interest. The method compares allelic and genotyping frequencies of a specific 
genetic marker between a group of unrelated cases and controls. One caveat to this method, 
however, is that it requires the genotype distribution of a particular marker in the control cohort 
to be in “Hardy-Weinberg Equilibrium” (HWE) (Schaid and Sommert 1993). HWE is a feature 
of a population where genotype and haplotype frequencies remain constant from one 
generation to the next in the absence of migration, natural selection, assortative mating, or 
mutation (Wigginton et al. 2005). Despite these factors being difficult to control for, most 
populations generally appear to adhere to the expected allele frequencies, and deviations from 
HWE at a particular locus may be suggestive of genotyping errors, extensive population 
structure due to admixture, or may appear in the affected individuals, thereby indicating an 
association between the marker and the disease under study (Wigginton et al. 2005).  
 
Numerous genes found throughout the genome have been shown to play a role in susceptibility 
to TB. Genes encoding a number of proteins such as the HLAs, NRAMP1, mannose binding 
lectin (MBL), IFN-gamma, and Vitamin D Receptor (VDR) have been associated with 
variations in susceptibility to TB (Bellamy et al., 1998; Søborg et al., 2003; Yim and Selvaraj 
2010). Amongst the genes evaluated are many with key roles in the functioning of the immune 
system such as those belonging to the HLA complex, NRAMP1 (SLC11A1), and IFN-. 
 
A large cohort of 1 916 sputum-positive pulmonary TB patients from Ghana were genotyped 
for the ALOX5 g.760G>A variant and individuals who were heterozygous for the 
polymorphism were found to be at increased risk for developing TB. Furthermore, harbouring 
this exonic variant had a greater association (OR= 1.70; (95% CI: 1.2–2.6)) with infection 
caused by M. africanum West African-2 (Herb et al. 2007). Modelling a recessive mode of 
inheritance, a protective association (OR= 0.60; (95% CI: 0.4–0.9)) was identified between the 
occurrence of TB and the MBL2 G57E variant in a cohort of Ghanaian patients (Thye et al. 
2011). TB patients belonging to the Ewe ethnic group were significantly more likely to be 
infected with M. africanum (OR= 3.02; (95% CI: 1.67–5.47)) and further stratification by 
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lineage revealed that the association was strongly driven by infection with members of 
M. africanum West Africa 1 (Asante-Poku et al. 2015). 
 
Using a candidate gene approach, polymorphisms in the CCL2 and NOS2A genes were 
investigated for more than 800 cases and controls belonging to the South African Coloured 
(SAC) population and the T allele of one SNP, rs8078340, was found to be significantly 
associated with having TB (OR=1.4; 95% CI: 1.1–1.8) (Möller et al. 2009). A recent study by 
Hong and others investigated a Korean cohort of 46 cases and 1 313 controls for genome-wide 
associations to TB. Although the authors were unable to identify novel SNPs significantly 
associated with the disease, the study was able to replicate associations between pulmonary TB 
and ten SNPs in, or in close proximity to a number of immune-related genes, as previously 
identified in another Korean cohort (Hong et al. 2017).  
 
A limitation of the candidate-gene study design, however, is that it requires an a priori 
hypothesis regarding genes to target in the association analysis. To tackle this limitation, 
genome-wide association studies (GWAS) have become a popular alternative for identifying 
genetic associations with disease. Through genotyping of many common genetic variants, 
GWA studies enable a global interrogation of an individual’s genome for associations to 
disease, without the limitation of predefined candidate genes (Hirschhorn and Daly 2005). 
 
 Genome-wide Association Studies (GWAS) 
GWA studies aim to identify SNPs that differ in frequency between disease cases and 
well-matched controls. To do so, participants are genotyped at 100s of 1000s to millions of 
pre-selected SNPs spanning the entire genome. As GWAS are hypothesis-generating, careful 
consideration is required when selecting variants to be included on the genotyping array. GWA 
studies focus on a notion of “common diseases harbour common variants” and thus generally 
focus on variants with frequencies greater than 5% in the population (Reich and Lander 2001). 
Given an adequate sample size, GWAS have greater power to detect genetic associations with 
small effects, compared to linkage studies (Risch and Merikangas 1996). 
 
The first TB GWAS reported an association between a region found on chromosome 18q11.2 
and TB susceptibility in a case-control study of TB patients from The Gambia and Ghana (Thye 
et al. 2010). Following this, 13 other TB GWAS have been performed (Table 2) and hold 
Stellenbosch University  https://scholar.sun.ac.za
   
 
 
 
17 
promise for refining the methods used to identify TB-related genetic associations (Uren et al. 
2017).  
 
In a modification of the traditional GWAS study design, Daya and others sought to identify 
interactions between gene pairs which may influence susceptibility to TB in the SAC 
population. The IL23R-ATG4C, GRIK1-GRIK3, and NRG1-NRG3 gene pairs were found to 
potentially be involved in susceptibility to TB. Various models of these three gene pairs were 
successfully validated in a secondary dataset from The Gambia (Daya et al. 2015).  
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Table 2: Results of previous TB GWAS studies as summarised by Uren et al. 2017 
Population Variant /Gene Number of 
Cases 
Number of 
Controls 
Reference 
Ghana rs4331426 (gene desert) 921 1 740 (Thye et al. 2010) 
The Gambia 1 316 1 382 
Black, White, Asian from USA rs4893980 (PDE11A) 48 57 (Oki et al. 2011) 
rs10488286 (KCND2) 
rs2026414 (PCDH15) 
rs10487416 (unknown gene) 
Thai and Japanese Intergenic region between HSPEP1-MAFB 620 1 524 (Mahasirimongkol  
et al. 2012) 
Indonesia rs1418267 (TXNDC4) 108 115 (Png et al. 2012) 
rs2273061 (JAG1) 
rs4461087 (DYNLRB2) 
rs1051787 (EBF1) 
rs10497744, rs1020941 (TMEFF2) 
rs188872 (CCL17) 
rs10245298 (HAUS6) 
rs6985962 (PENK) 
Ghana rs2057178 (WT1, intergenic) 2 127 5 636 (Thye et al. 2012) 
The Gambia 1 207 1 349 
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Russia 1 025 983 
Indonesia 4 441 5 874 
South African Coloured rs2057178, rs11031728 (WT1, intergenic)  642 91 (Chimusa et al. 2014) 
rs10916338, rs1925714 (RNF187) 
rs6676375 (PLD5) 
rs1075309 (SOX11) 
rs958617 (CNOT6L) 
rs1727757 (ZFPM2) 
rs2505675 (LOC100508120) 
rs1934954 (CYP2C8) 
rs12283022, rs12294076 (DYNC2H1) 
rs7105967, rs7947821 (DCUN1D5) 
rs6538140 (E2F7) 
rs1900442 (VWA8) 
rs17175227 (SMOC1) 
rs40363 (NAA60) 
rs2837857 (DSCAM) 
rs451390 (C2CD2) 
rs3218255 (IL2RB) 
Russia rs4733781, rs10956514, rs1017281, 
rs1469288, rs17285138, rs2033059, 
5 530 5 607 (Curtis et al. 2015) 
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rs12680942 (ASAP1) 
Morocco rs358793 (Intergenic) 556 650 (Grant et al. 2016) 
rs17590261 (Intergenic) 
rs6786408 (FOXP1) 
rs916943 (AGMO) 
Uganda and Tanzania rs4921437 (IL-12) 267 314 (Sobota et al. 2016) 
Iceland rs557011, rs9271378  
(located between HLADQA1 and HLA-DRB1) 
8 162 277 643 (Sveinbjornsson et al. 
2016) 
rs9272785 (HLA-DQA1) 
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 Controlling Population Stratification in a GWAS 
Some of the limitations of GWAS studies include insufficient sample sizes, poor definitions of 
case and control groups, and controlling for population stratification. In addition, GWAS have 
inherent statistical challenges due to the large number of variants being examined within a 
large cohort under study. Thus, one of the major limitations of GWAS is the possibility of 
false-negative or false-positive associations being detected, which may be mitigated by 
statistically correcting for multiple testing (Visscher et al. 2012). 
 
Population genetic variation, commonly termed “population stratification” results from the 
admixture of different founder populations, and is evidenced by differences in allele 
frequencies in subpopulations (Cardon and Palmer 2003). If not corrected for during the 
statistical analyses, population stratification may result in false associations with the disease of 
interest (Oetjens et al. 2016; Daya et al. 2013).  
 
A number of software programs have been developed which allow for the quantification of 
population stratification for inclusion as a covariate in the statistical analysis phase of GWAS 
and candidate gene association studies. These software programs include among others, 
EIGENSTRAT (Price et al. 2006), ADMIXTURE (Alexander et al. 2009), RFMix (Maples et 
al. 2013), and STRUCTURE (Pritchard et al. 2000). The inclusion of principal components 
calculated from the genotype data is also a valid method for correcting for population 
stratification (Price et al. 2006). 
 
Population stratification resulting from admixture is an important factor which has been shown 
to confound the results reported in many genome-based association studies. As most published 
GWAS have been performed on populations originating from Europe, replication of GWAS 
results obtained from these populations in other distinct populations have proven difficult due 
to population stratification confounding results of association analyses (Need and Goldstein 
2009). It has therefore not been established as to what degree European GWAS data can be 
used to infer the population structure and allelic frequencies in cohorts belonging to historically 
older populations such as those originating from Africa (Martin et al. 2017). To correct for the 
confounding effect of variable ancestry, ancestry proportions need to be derived for the 
population of interest using software such as those described and included as covariates in the 
statistical analyses (Pearson and Manolio 2008).  
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The SAC population is a highly admixed population historically residing in the Western Cape 
Province of South Africa. In this province, the SAC population makes up a significant 
proportion of the local population; the 2011 Census reported the “Coloured” population 
comprising 42.4% of the population residing in the Western Cape (Strategic Development 
Information and GIS Department and City of Cape Town 2012). An analysis of the population 
substructure of the SAC population, showed that the five-way admixed population has genetic 
contributions from the Khoesan Africans, non-Khoesan Africans, European, South and 
East-Asian populations (De Wit et al. 2010). These ancestry proportions can be accurately 
determined using a set of 96 ancestry informative markers (AIMs) in individuals belonging to 
the SAC population, and furthermore serves to adjust for confounding when included as 
covariates in an association analysis (Daya et al. 2013). 
  
The software package, PROXYANC, was also developed to provide a platform for identifying 
the best reference populations for local ancestral contributions within a five-way admixed 
population such as the SAC (Chimusa et al. 2013). Selecting a reference population for a 
complex admixed population such as the SAC is not an easy task, and poorly selected 
references may negatively impact the statistical power to detect an association. PROXYANC 
serves to improve the selection of appropriate ancestral populations in admixture mapping 
studies and imputation of missing data in admixed genotypes (Chimusa et al. 2013).  
 
The SAC population presents with a unique genotype composition, with individuals 
predominantly located within an environment of high TB incidence. The combination of 
complex admixture and observed high TB incidence may contribute to the TB burden seen in 
the Western Cape region of South Africa. It also serves as an ideal highly admixed population 
for studying the genetic susceptibility to the many M. tb clades causing disease in this region, 
presenting an opportunity for unique studies of association. 
 
Chimusa and colleagues performed a GWAS on a cohort belonging to the SAC population in 
which genotypes were imputed with the HapMap3 release 2 and 1000 Genomes Project 
(1000GP) reference populations (Chimusa et al. 2014). Using a mixed model approach, the 
authors aimed to replicate TB susceptibility loci identified from previous studies, in this 
population (Chimusa et al. 2014). The authors were able to replicate the susceptibility locus 
(rs2057178) located in the WT1 gene on chromosome 11, as identified in cohorts of TB patients 
in The Gambia, Indonesia, and Russia (Thye et al. 2012). This study by Chimusa described 
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evidence that disease associations may be stratified by ethnicity and strongly influenced by 
ancestry. 
 
A recent post-GWAS analysis was performed to predict regulatory variants potentially 
associated with susceptibility to TB. Using bioinformatics analyses incorporating 
RegulomeDB and Ensembl’s Variant Effect Predictor, the authors fine-mapped six statistically 
significant novel intronic polymorphisms not identified by previous GWAS studies performed 
in the same cohort (Uren et al. 2017). The study showed that beyond the results of a GWAS, 
further bioinformatic analyses hold potential for identifying novel disease variants in silico. 
 
To address the TB epidemic, multiple avenues of research need to be conducted (Stein 2011). 
To this end, numerous studies have focussed on finding genetic associations with the disease 
and have provided promising candidates for further investigation as TB biomarkers and targets 
for host-directed therapies, such as the granuloma, induction of autophagy, and 
anti-inflammatory responses (Kolloli and Subbian 2017). One area of TB research sparsely 
investigated is the potential associations between the human genome and different strains of 
M. tb circulating within high-risk communities. Understanding the biological mechanisms 
driving this complex relationship between host and pathogen will improve our existing 
knowledge of the disease and provide further avenues of exploration for improving the lives of 
millions affected by TB. 
 
2.6. Genetic associations with different M. tb strains 
 Origin and epidemiology 
Several species within the MTBC are known pathogens and include M. tb, M. africanum, 
M. bovis, M. canetti, and M. microti. and despite sharing 99.9% nucleotide similarity, have 
shown stark variations in their host of choice, level of pathogenicity, and phenotype (Brosch 
et al. 2002). The MTBC has been described as consisting of eight lineages: seven lineages 
deriving from a common ancestor are adapted to cause disease in humans, and one lineage is 
known to cause TB in animals (Comas et al. 2013; Wirth et al. 2008). Phylogenetic studies 
have demonstrated that based on the presence or absence of a gene deletion, and the fact that 
horizontal gene transfer is unheard of in members of the MTBC, the lineages can be classified 
as ‘modern’ or ‘ancient’ (Brosch et al. 2002). Strains considered to have evolved more recently 
and are therefore considered more ‘modern’, are classified as such based on the deletion of the 
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TbD1 region and presence of the RD9 region, whereas strains in which the TbD1 region had 
not been deleted, but were lacking the RD9 region are considered to be evolutionarily ‘ancient’ 
strains (Brosch et al. 2002; Gutierrez et al. 2005). 
 
The seven human-adapted MTBC lineages comprise five members belonging to the 
M. tb sensu stricto species as well as two members belonging to the M. africanum species. 
Several human-adapted strains have been classified as belonging to one of three ‘modern’ 
lineages based on a deletion of the TbD1 gene. Lineages 2, 3, and 4 geographically dominate 
most of East-Asian, East-African, European and American countries, respectively (Figure 2). 
 
The animal-adapted species, namely M. bovis, M. canetti, and M. microti, as well as 
human-adapted strains belonging to Lineages 1, 5, 6, and 7, have been classified as ‘ancient’ 
members of the MTBC. Lineage 1, also known as the Indo-Oceanic lineage, is found mainly 
in populations residing in the Indian Ocean and the Philippines (Figure 2). Lineages 5 and 6 
are composed of the M. africanum West-Africa 1 and West-Africa 2 strain families, 
respectively (Figure 2). The geographical isolation of these two lineages to West-African 
countries may possibly be explained by the strains having more time than the ‘modern’ lineages 
to establish itself as a pathogen causing stable disease in a sympatric population which has 
co-evolved to survive infection with the bacterium. Lineage 5 and 6 have also been established 
as having high genomic variability, possibly contributing to drug-resistance mechanisms, 
immunogenic effects, and protein secretion (Ates et al. 2018; Otchere et al. 2018).  
 
A novel lineage, Lineage 7, was recently defined as a predominant lineage in Ethiopia and 
other countries in the Horn of Africa (Firdessa et al. 2013). A total of 36 isolates obtained from 
patients with lymph node or pulmonary TB presented with previously undefined spoligotyping 
patterns. Although the isolates had intact TbD1 deletions similar to that of the modern lineages, 
they had other distinguishing features which led to their classification as belonging to the novel 
Lineage 7, which localises phylogenetically between the ancient Indo-Oceanic lineage 1, and 
modern TB lineages 2, 3, and 4 (Blouin et al. 2012; Firdessa et al. 2013). Strains belonging to 
Lineage 7 reportedly grew slower than other strains of M. tb and patients infected with this 
lineage took a median of three weeks from the onset of symptoms to report to their health care 
provider, with the authors hypothesising that Lineage 7 strains caused milder symptoms than 
the other, more virulent strains (Yimer et al. 2015). This intermediary effect of the bacterium 
Stellenbosch University  https://scholar.sun.ac.za
   
 
 
 
25 
on the host may possibly be explained by their phylogenetic localisation between the ancient 
and modern strains.  
 
In contrast to the known pathogenicity of the ‘ancient’ strains (Gonzalo-Asensio et al. 2018), 
the evolutionarily ‘modern’ strains such as members of the Beijing family (lineage 2) and 
Haarlem family (lineage 4) have been described as hypervirulent and capable of causing severe 
disease in susceptible populations (Brites and Gagneux 2015; Hoal et al. 2017). Members of 
these two lineages have been a major cause for concern as they have been implicated in 
drug-susceptible and drug-resistant outbreaks of the disease. 
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Figure 2: The phylogeny of members of the MTBC as derived using Maximum Parsimony, as published in de Jong et al. (2010), adapted from 
Hershberg et al. (2008). The figure is further adapted using the phylogeography as published in Gagneux and Small (2007) with Spoligotyping 
annotation from Brudey et al. (2006). The recently described Lineage 7 is not annotated on this phylogenetic tree. 
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Global TB outbreaks have been noticeably dominated by specific lineages in defined geographical 
regions (Gagneux and Small 2007). This observation has been substantiated by the dominance of all 
six M. tb lineages across the African continent, while in Asia, M. tb lineages 5 and 6 are largely absent 
(Figure 3). Continental separation of MTBC lineages has been observed, with Lineage 4 dominating 
most of Europe, the Americas and Australia. East Asia is dominated by four of the six lineages, 
whereas all six lineages can be found within the African continent (Gagneux and Small 2007; Chihota 
et al. 2018). 
 
Advancements in technology and accessibility to international modes of travel have greatly increased 
the transmission of many communicable diseases, including TB (Knobler et al. 2006; Zumla et al. 
2016). However, the geographical dominance of M. tb lineages in different parts of the world 
contradicts the idea that all strains have equal access to different populations across the globe. Thus, it 
has been strongly suggested that the genetic make-up of the host may play a significant role in defining 
the susceptibility to strains found to infect a given population (For Reviews see: (Abel et al. 2017; 
Meyer and Thye 2014; Moller and Hoal 2010)). 
 
 
Figure 3: Global distribution of dominant M. tb phyla as originally published by Gagneux and Small 
(2007). Southern Africa is dominated by lineages 2 and 4 comprising Beijing, Haarlem, LAM, and T, 
whilst West Africa is dominated by lineages 5 and 6, namely WA1 and WA2, with interplay from 
Lineage 4. 
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2.6.1.1. South Africa 
South Africa is dominated by lineages 2 and 4 comprising the Beijing, Haarlem, LAM, and T clades 
(Figure 3). A recent study by Sekati and others investigated the drug-susceptibility patterns and 
spoligotype distributions of M. tb amongst 104 clinical isolates from children in several provinces in 
South Africa including Gauteng, the North West, Limpopo, and Mpumalanga. The study revealed 21 
strains from 93 isolates which could be classified according to their spoligotype signature. 
Furthermore, members of the Beijing strain family were reported as dominant strains in all four 
provinces, followed by the T, and Latin American-Mediterranean (LAM) subtypes (Sekati et al. 2015). 
Another study by Hove and others investigated the spoligotype distribution of M. tb isolates from 
adults in the Soshanguve township in Pretoria, Gauteng. From 89 M. tb positive isolates, 75 were 
grouped into clusters. The Beijing clade formed the largest group of 28% of the isolates, followed by 
the LAM3, LAM4, and LAM9 strain family members making up 13%, 4%, and 3%, respectively 
(Hove et al. 2012). 
 
For the Western Cape Province of South Africa, the most recent investigation of M. tb clade 
distribution described 2 727 cases of TB for 2 150 patients in which both drug-susceptible, and 
drug-resistant M. tb cases were investigated. Of the participants recruited, 1 737 were infected by a 
drug-susceptible M. tb strain. Eight clades could be derived for the collection of strains evaluated, of 
which the dominant clades were Beijing, LAM, Low-Copy clade (LCC), Haarlem, and lastly, Quebec 
(van der Spuy et al. 2009).  
 
Using non-linear regression analysis, the numbers of annual TB cases attributed to infection with the 
Haarlem, Quebec, LCC, and LAM families did not increase significantly over the study period from 
January 1993 to December 2004. In contrast, the Beijing strain produced a logistic increase over time, 
demonstrating a significant increase in the number of TB infections caused by this strain (van der Spuy 
et al. 2009). Unlike the West-African region, Southern Africa has not shown a predominance for TB 
caused by M. africanum (Demers et al. 2010). 
 
2.6.1.2. Ghana 
West Africa is dominated by lineages 5 and 6, namely WA1 and WA2, with interplay with Lineage 4 
(Figure 3). In contrast to the dominance of M. tb strain families in South Africa, Ghana’s pulmonary 
TB epidemic is largely driven by infection with M. africanum, with some disease cases resulting from 
infection with M. tb. First identified in Senegal in 1968 by Castets and colleagues, M. africanum was 
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classified as type 1 and type 2 intermediary species between M. tb and M. bovis (de Jong et al. 2010). 
However, as a result of genomic deletion studies, M. africanum type 2 was reclassified as M. tb 
“Uganda sublineage” as it was found to be a sub-lineage of M. tb lineage 4 (Niemann et al. 2002). 
 
M. africanum, originally known as M. africanum type 1, is further classified into two distinct lineages, 
M. africanum West African 1 (M. africanum 1) and M. africanum West African 2 (M. africanum 2), 
each occupying specific geographical niches in West Africa (Figure 4). Spoligotyping of M. tb isolates 
belonging to Lineage 3 revealed the Ghana, Haarlem, Uganda I, Uganda II, LAM, New_1, and 
H37Rv_like sub-lineages to be circulating in Ghana (Asante-Poku et al. 2016). The distribution of 
M. tb clades dominating TB infections in South Africa is unknown in Ghana. 
 
 
Figure 4: Prevalence of M. africanum in West Africa as originally published in de Jong et al. (2010). 
 
 Investigating the genetic susceptibility of the host to different M. tb strains 
A number of studies performed to date have linked various disease phenotypes to host genotypes 
through SNP association testing. The number of phenotype definitions are endless and may be related 
to patient response to disease such as disease states, measured physiological parameters, or may be 
classified according to the infecting pathogen, such as different strains. 
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Susceptibility of the human host to infection with different strains of M. tb has only in recent years 
gained some attention. The first study to investigate host genotype-bacterial strain interactions was 
performed by Caws et al. on a cohort of 237 Vietnamese adults with pulmonary TB. Significant 
associations were found between genotypes with the C allele (T597C), of the toll-like receptor-2 gene 
(TLR2) and the bacterial strain and individuals with this allele were more likely to develop TB caused 
by mycobacteria belonging to the East-Asian/Beijing strain family (OR = 1.57 [95% CI 1.15-2.15]) 
(Caws et al. 2008). However, the study design was of the nature that genes of interest were pre-selected 
based on previous TB susceptibility studies. 
 
HLA types are known to be important in the immune response to pathogens. In a candidate-gene study, 
HLA types were investigated for associations between the HLA alleles of individuals self-identifying 
as belonging to the SAC population, and the M. tb strain responsible for their active TB (Salie et al. 
2014). Individuals with the HLA-B27 allele were shown to be at decreased risk for having an additional 
infection by a Beijing strain, when they had multiple episodes of infection with a Beijing strain. 
Specific HLA types were also found to be associated with disease caused by the different strains 
investigated (Salie et al. 2014) 
 
While comprehensive methods have been developed for performing traditional case-control GWAS, 
research methods for analysing multiple phenotype-to-genotype associations for infectious diseases is 
still in its infancy. Genotype-first GWAS aim to test for associations between thousands of variants 
and a single trait of interest, such as a disease or health-related trait, in a case-control study design. A 
variation of this GWAS is the phenotype-first GWAS (PheWAS) in which the participants are 
classified according to phenotype. A phenome scan is used to test for association between genotypes 
and a comprehensive list of phenotypes. Variations in phenome scans include environment-wide 
association studies (EnWAS) and Mendelian randomization-PheWAS (Millard et al. 2017). 
 
A phenome-wide association study (PheWAS) is a novel algorithm scanning for associations between 
targeted genotypes and numerous phenotypes (Denny et al. 2010). The pairing of genetic data with 
electronic medical records provides a platform for investigating phenome-wide associations to specific 
genetic markers of interest. In the proof of concept study, a cohort of 6 005 individuals of 
European-American ancestry were genotyped for five SNPs which have been reported in previous 
studies to be associated with seven common non-infectious diseases. In this study, the authors were 
able to replicate four out of seven known SNP-disease associations with significant P-values. The 
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algorithm was also able to identify 19 novel statistical associations between the genotyped SNPs and 
the diseases queried, at a P-value less than 0.01 (Denny et al. 2010). 
 
A follow-up study included 13 835 individuals of European ancestry who were analysed for 
associations between 3 144 genotyped SNPs and 1 358 phenotypes. The study replicated 66% of 
previously reported GWAS associations with sufficient statistical power and reported 63 associations 
with potential pleiotropy (Denny et al. 2013). Although this study demonstrated the importance of 
investigating genotype-phenotype associations, it focussed on a targeted set of SNPs with a priori 
association to disease. 
 
A recent study aimed to identify genome-wide associations with TB onset, stratifying by infecting 
M. tb lineage, and the age at onset in a cohort of Thai participants (Omae et al. 2017). The study 
initially attempted to identify age-related associations between five M. tb lineages and two 
age-stratified groups of TB participants, namely 219 young cases (under the age of 45), and 467 old 
cases (over the age of 45). To reduce the complexity of the association tests, the M. tb lineages were 
tested as one lineage versus a collective of all other lineages. After applying Bonferroni corrections, 
the authors were unable to locate SNPs with genome-wide significance in either of the age-groups for 
any of the five M. tb lineages. However, when reducing the five lineages to two groups consisting only 
of ‘Beijing’ and ‘non-Beijing’ cases, and testing for age-related association to TB, the authors 
identified a single SNP on chromosome 1p13, rs1418425, reported to have a significant association to 
non-Beijing infected cases classified in the “old” age category (P = 1.58 x10-07 OR = 1.62 
[95% CI 1.35-1.93]). The authors were able to replicate the SNP in two independent cohorts, further 
demonstrating the importance of performing GWAS with a specific focus on pathogen lineage (Omae 
et al. 2017). 
 
As presented in this literature study, numerous pieces of evidence for genetic associations to disease 
have been demonstrated since the advent of TB research. However, only one recent study has 
attempted to investigate the association between the human genome and different members of the 
MTBC causing TB. By not placing the pathogenic nature of the MTBC members in a single biological 
basket, we endeavour to untangle some of the complexities driving this scourge of humanity. 
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CHAPTER THREE 
3. Materials and Methods Chapter Overview: 
Chapter 3 of this dissertation describes the materials to develop the bioinformatics-based 
methods that enabled us to perform a genome-wide association analysis between human 
genotypes and the infecting M. tb clade responsible for the disease status of study participants 
(Figure 5). This study relied heavily on the provision of data from paired patient samples (blood 
and sputum) in order for the computational methods to be developed. Thus, the genotype data 
and M. tb isolate data used in this study were generated as part of previous studies and archived 
for further analysis. Sections 3.1.1 to 3.1.2 were performed in these previous studies and are 
described for background purposes. To reduce redundancy in explanation, subsequent steps are 
presented simultaneously for both cohorts. 
 
Two cohorts are described in the present study. The paired data for the first cohort, the SAC 
cohort, is housed at Stellenbosch University and was readily available for method development 
described in this dissertation. A second cohort, from Ghana, was obtained once the method had 
been established, and tested the ability to perform an association analysis with the given 
method.  
 
All subsequent methods described herein were developed for the current dissertation. All R 
scripts were written by the author of this dissertation, unless otherwise stated, and duly cited. 
All R scripts were written using R version 3.4.0 “You Stupid Darkness” (R Core Team 2017), 
and associated packages are cited in-text. Ethics approval for the current study was granted by 
the Health Research Ethics Committee at Stellenbosch University (Project number: 
S17/02/037).  
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Figure 5: Workflow designed to enable an association analysis of genome-wide host SNP 
markers to multiple classes of infecting M. tb isolates.  
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3.1. Participant recruitment and sample collection 
Sections 3.1.1 to 3.1.2 below describe the collection of blood and sputum samples from patients 
recruited into the SAC or Ghanaian cohort. At the time of recruitment for the SAC cohort, two 
separate studies contributed data - one study focussed on collecting blood for genotyping, while 
a second, independent study was concerned with collecting sputum for an epidemiological 
study. However, not all patients had both blood and sputum samples collected during the 
sampling period. Thus, it was necessary to match patients who had been genotyped to records 
of their sputum collection in a second database. The details of this process is described in the 
paragraphs that follow. 
 
 Participant recruitment 
3.1.1.1. SAC cohort 
For the SAC cohort, study participants were recruited as part of a previous TB epidemiology 
study in the Western Cape Province of South Africa during the period of January 1993 through 
December 2004 (Project number: 95/072) from suburbs where the TB incidence was high 
(28.9 % in 2005) and the prevalence of HIV was a low 2% (Kritzinger et al. 2009; Shisana et 
al. 2012). All study participants self-identified as belonging to the SAC population, were 
HIV-negative, and provided written informed consent. All subsequent research was conducted 
according to the principles expressed in the Declaration of Helsinki (WHO 2001).  
 
Blood and sputum samples were collected from each study participant as approved by the 
Health Research Ethics Committee at Stellenbosch University (Project numbers: S17/01/013 
and 95/072). DNA was extracted from blood samples using the Nucleon BACC Genomic DNA 
extraction kit (Illumina, Buckinghamshire, UK) and genotyped on two platforms: the 
GeneChip Human Mapping 500K SNP array (Affymetrix, subsidiary of Thermo Fisher 
Scientific, California, United States) and the Infinium Multi-Ethnic Genotyping Array 
(MEGA) (Illumina, California, United States). 
 
3.1.1.2. Ghanaian cohort  
For the Ghanaian cohort, study participants were enrolled in Ghana, West Africa, between 
September 2001 and July 2004. All cases were HIV-negative and confirmed to have pulmonary 
TB by two independent radiologists (Thye et al. 2012). Ethics approval for the sample 
collection was granted by the Committee on Human Research, Publications and Ethics, School 
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of Medicine Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, 
Ghana, and the Ethics Committee of the Ghana Health Service in Accra, Ghana (Thye et al. 
2012). 
 
 Sample processing 
3.1.2.1. SNP Genotyping 
3.1.2.1.1. SAC cohort 
DNA was extracted followed by SNP genotyping using the Affymetrix 500K array. 
Genotype-calling was performed using the Affymetrix Power Tools pipeline (V1.10.0) as 
previously described (De Wit et al. 2010). For a subset of individuals in the SAC cohort, DNA 
was genotyped using the Multi-Ethnic Genotyping Array (MEGA) from Illumina. Following 
standard genotyping quality control (QC), ancestry proportions for the SAC cohort on the 
Affymetrix 500k array were estimated using the unsupervised algorithm implemented in 
ADMIXTURE (Daya et al. 2013). For the genotype data obtained from the MEGA array, 
genotype-calling was performed using Genome studio v2.04 and following standard genotype 
QC, ancestry proportions were estimated (Schurz et al. 2018) using the ADMIXTURE software 
(Alexander et al. 2009). 
 
3.1.2.1.2. Ghanaian cohort  
DNA extracted from blood samples was genotyped using the Affymetrix SNP 6.0 array at the 
Affymetrix Services Laboratory in California, and at ATLAS Biolabs GmbH in Berlin. 
Genotypes were called using the Birdseed version 2 algorithm and using the Eigenstrat 
software, ancestry proportions in the form of principal components were derived (Thye et al. 
2012). For both cohorts included in this study, genotype data was made available in PLINK 
(Purcell and Chang, n.d.; Chang et al. 2015) format as described in Table 3. 
  
Stellenbosch University  https://scholar.sun.ac.za
   
 
 
 
36 
Table 3: PLINK file formats 
PLINK file type Column Descriptions 
PED Family ID, Individual ID, Paternal ID, Maternal ID, Sex, Phenotype 
MAP Chromosome, SNP ID, Genetic distance, Physical position 
BED Binary PED file 
BIM Chromosome, SNP ID, Genetic distance, Physical Position, Allele 1, 
Allele 2 
FAM Family ID, Individual ID, Paternal ID, Maternal ID, Sex, Phenotype 
 
3.1.2.2. Spoligotyping // IS6110 RFLP records 
3.1.2.2.1. SAC cohort 
For each infection, sputum samples were collected from participants for bacterial culture on LJ 
media. M. tb isolates were identified using spoligotyping and IS6110 Restriction Fragment 
Length Polymorphism (RFLP) methods as previously described (van der Spuy et al. 2009). All 
M. tb infection data were entered onto manually-curated departmental databases for archiving.  
 
3.1.2.2.2. Ghanaian cohort 
M. tb isolates extracted from sputum samples were cultured on LJ media at the Kumasi Centre 
for Collaborative Research (Owusu-Dabo et al. 2006). Strains were identified by IS6110 RFLP 
and spoligotyping (Supply et al. 2006). 
 
3.2. Defining M. tb clades and superclades 
M. tb clades were grouped into superclades by clustering closely-related clades near a point of 
divergence on a SNP-based phylogenetic tree of M. tb (Figure 6) (Dippenaar 2014). This was 
performed to reduce the number of clades of low frequency into superclades with higher 
frequency, as low frequency groups are known to induce an unfavourable collinearity effect on 
logistic regression models (Bergtold et al. 2011). Clades remaining unchanged were also 
referred to as “superclades” after clustering. Clades present in the Strain database, but not 
represented on the phylogenetic tree, were kept as distinct groups and not clustered with any 
of the members on the existing tree, except when a suitable reference phylogeny was found. 
After clustering, superclades with a frequency less than ten in the study dataset were excluded 
from subsequent analyses. 
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3.3. Preliminary assessment of paired data 
A preliminary assessment using PCA was conducted to determine whether there was 
potentially a relationship between the host genotypes and the occurrence of specific infecting 
M. tb clades. Following standard genotyping QC, a PCA was performed using the infecting 
clade data and genotype data that had passed through several QC filters. 
 
 Genotype QC 
To prepare the patient genotypes for a preliminary analysis of the association with the M. tb 
clades and superclades, variants lacking chromosome and/or base pair annotation were 
excluded from the PLINK files for all participants. This was followed by iterative QC filters 
for a maximum of 10% individual genotype missingness (--mind), 2% SNP genotype 
missingness (--geno), and 5% SNP minor allele frequency (MAF; --maf) using PLINK. These 
iterations alternated with a “sex” check and identification of duplicate samples at a level of 
first-cousin relatedness (pi-HAT > 0.125). A Perl script written by Yekai Xiong (Chang et al. 
2014; Gao et al. 2015) was used to identify one individual per related pair who needed to be 
removed. This was followed by a test for excess heterozygosity in PLINK to identify 
individuals with genotyping heterozygosity four standard deviations from the mean. These 
individuals were removed from the dataset. PCA was performed to identify outliers in the 
dataset and any separation of the genotype data based on M. tb clades and superclades.  
 
 M. tb database quality control 
3.3.2.1. SAC cohort 
Two archived in-house databases were used to retrieve information of the infecting M. tb clade 
for the SAC cohort. One database contained patient records and is referred to as the “Patients 
database” and is abbreviated “P”, while a second database contained spoligotyping records for 
study participants from which M. tb cultures had been derived (Table 4). As the M. tb database 
consisted of multiple levels of information for the bacterium, it is herein referred to as the 
“M. tb database” and is abbreviated “S” for “Strain”. 
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Table 4: Database sources used to complete this objective 
Data source Column Descriptions Number of 
observations 
Patients 
database 
 (P) 
Case ID, PatientID, Date of Birth, Gender, Clinical 
Disease 
 
3 937 
M. tb database 
(S) 
Patient ID, Culture Date, SAWC, IS6110_3, Family, 
Family Group, Type, Description, Infection, 
Reactivation, Evolved 
4 583 
SAC cohort Family ID, Individual ID, Sex, Phenotype 
(extracted from PLINK .fam file) 
  947 
link Case ID, Sample ID 4 408 
 
Bash shell scripting was used to extract the Family ID, Individual ID, Sex, and Phenotype 
columns for the genotyped individuals and an R script was written to link the genotyped study 
participants to their corresponding M. tb infections. Once M. tb clade-matched study 
participants who were also genotyped were identified, QC was performed on the patient records 
as follows: the first QC measure was to identify any individuals who may have had duplicate 
records as a result of being genotyped more than once. If any individual had been genotyped 
more than once, the raw genotype-calling quality scores of each sample was compared, 
followed by the removal of the sample with the poorer quality score from the dataset. The 
second QC measure was to identify and correct incorrect assignments of infection number. 
 
3.3.2.2. Ghanaian cohort 
Host genotype data and bacterial strain data were generously provided by Dr Thorsten Thye 
and Prof Stefan Niemann, and was assessed using the same QC filters as those used on the 
SAC dataset. 
 
 Derive M. tb distributions 
M. tb clade and superclade distributions were derived for subsets of the study cohort. If records 
for multiple infections were available, M. tb distributions were derived for the first infection 
recorded for each patient present in the database, as well as any subsequent infections. 
Distributions of M. tb isolates were also computed for the subsets of study participants having 
only one infection recorded in the PS database, and those having multiple infections.  
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It is possible for study participants to have been sampled multiple times during the recruitment 
period and a number of possibilities exist which may confound the representation of an M. tb 
infection. We acknowledge that these individuals may have gone to different clinics during the 
sample collection period or may have failed to return to the clinic. Thus, it is possible that a 
subsequent M. tb infection may be misrepresented with regards to the true order of events or 
may not be recorded in the Strain database at all. For this reason, we took the pragmatic 
approach of analysing the first recorded infection for each patient during the sample collection 
period. Frequency distributions of clades and superclades were reported for the first- and 
second infection records, where available, as well as for study participants having only one 
recorded infection in the database, and two recorded infections in the database. 
 
 PCA of first recorded infection 
Genotypes for the samples passing the QC filters were converted to the genomic data structure 
(gds) format using the gdsfmt (Zheng et al. 2012) package in R. PCA was performed on the 
genotype data using the snpgdsPCA function available within the SNPRelate package (Zheng 
et al. 2012). Eigenvalues generated from the PCA were plotted in a scree plot and visually 
inspected to identify at which eigenvalue the variation in the data became least explicable. PCA 
plots were generated by selecting paired eigenvalue columns and plotting them combined with 
an overlay of either the clade, or superclade. 
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3.4. Generate high-quality imputed genotype data 
Prior to performing an association analysis, a critical step is to obtain high quality genotype 
data by filtering for SNP genotype missingness, sample missingness and minor allele 
frequency. Additionally, variants lacking chromosome or base pair information were updated 
using the 1000 Genomes Phase 31 (1000GP3) reference panel and the dbSNP database. To 
maximise the number of variants tested in the association analysis, the cleaned genotype data 
were imputed using three different reference panels to determine which panel served the best 
for the given dataset in imputing missing variants. 
 
 Modified Data QC for Imputation 
3.4.1.1. Update variants lacking chromosome or base pair position 
information 
Instead of discarding unannotated SNPs as was done in 3.3.1, chromosome and base pair 
position annotations were retrieved for SNPs lacking this information. To do this, the SNP 
overlap between the 1000GP3 reference panel and the study dataset was calculated. 
Chromosome and base pair position annotations were retrieved from the 1000GP3 and only 
SNPs also found to be validated by laboratory methods in the dbSNP2 database were retained 
and subsequently updated for their missing information. SNPs found in the 1000GP3, but not 
validated according to dbSNP were removed from the study dataset. 
 
3.4.1.2. Examine the data for ambiguity in alignment to reference data 
When genotype data are generated, the reference panel used in the array design may be an 
outdated version of the most recently updated human reference panel (Wang et al. 2017). In 
regions where the reference panel has been updated with “strand flips” or “SNP flips”, the 
original genotype data may not be completely oriented in the same way as the reference 
genome, and the process of genotype imputation may be erroneous. Thus, to facilitate accurate 
genotype imputation and meta-analyses of datasets genotyped on different platforms, it is 
essential that study data be oriented to the strand direction of the reference data (Deelen et al. 
2014). 
 
                                                 
1 ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/phase3/ 
2 ftp://ftp.ncbi.nih.gov/snp/  
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A previous researcher in our group, Dr Michelle Daya, used LiftOver1 to convert the 
Affymetrix genotyping data for the SAC cohort from build 36 of the human genome reference 
(which was used in the array design) to build 372. LiftOver updates SNP IDs (rs numbers) 
and/or genomic co-ordinates (base pair positions) between the assembly on which the input 
genotyping data was generated, aligned to the desired (generally, more recent) reference 
genome assembly. 
 
Using Genotype Harmonizer3 (Deelen et al. 2014), genotyping data were aligned to match the 
strand direction used in the 1000GP3 reference dataset. The study genotypes were entered into 
Genotype Harmonizer using default parameters along with flags to update the study variant 
IDs, match the study reference alleles, and to keep variants not in the reference dataset. The 
linkage disequilibrium (LD) checker was kept off as default, and a maximum MAF of 0.05 was 
included as a back-up filter. In instances where insufficient variants were in LD and the MAF 
of a variant was less than or equal to the specified value in both study data as in the reference, 
the minor allele was used as a backup for alignment. 
 
3.4.1.3. Genotype QC 
Following alignment of alleles to the 1000GP3 reference panel with Genotype Harmonizer, 
genotyping QC was performed using PLINK and consisted of iterative filters for 10% sample 
missingness, 2% SNP genotyping missingness, and a 5% MAF filter, until no more SNPs or 
samples were removed. These three filters alternated with a “sex” check, and check for too 
little, or excessive genotyping heterozygosity. Too little genotyping heterozygosity amongst 
participants in the sample may be an indication of inbreeding, whereas excessive 
heterozygosity may be indicative of sample contamination (Anderson et al. 2010). Related 
individuals were identified but not removed from the dataset at this stage because increased 
sample sizes, regardless of relatedness, have been shown to improve phasing and imputation 
accuracy (Deelen et al. 2014). 
 
                                                 
1 http://genome.ucsc.edu/cgi-bin/hgLiftOver 
2 http://hgdownload.cse.ucsc.edu/goldenPath/hg19/chromosomes/ 
3 http://www.molgenis.org/downloads/GenotypeHarmonizer/GenotypeHarmonizer-1.4.20-dist.tar.gz  
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 Data preparation, Haplotype phasing, and Genotype imputation 
3.4.2.1. In-house (IH) workflow 
Haplotype phasing and genotype imputation was performed using five workflows as shown in 
Table 5. For the In-House workflow (abbreviated as IH-1000GP3), genotypes in PLINK format 
passing QC filters were phased per chromosome using ShapeITv2 (Delaneau et al. 2008). The 
PHASER mode (version 2.r837) of the ShapeITv2 algorithm was kept at a default of 35 
Markov Chain Montecarlo (MCMC) iterations and the effective population size was specified 
as 15 000. Due to the admixed nature of the SAC population, the effective population size for 
the cohort was determined as an intermediate value of those suggested on the ShapeITv21 
website. The window-based model used 100 states per window, approximately 2 Mb in size. 
When phasing the X chromosome, males and females were split and heterozygous haploid 
variants were identified and removed using PLINK. 
 
Table 5: Haplotype phasing and Genotype Imputation workflows 
Workflow name Reference 
Panel 
Abbreviation 
used 
Phasing 
software 
Imputation 
software 
In-house 1000GP3 IH-1000GP3 ShapeITv2 IMPUTE2 
Michigan Imputation Server 1000GP3 MIS-1000GP3 ShapeITv2 Minimac3 
Michigan Imputation Server CAAPA* MIS-CAAPA ShapeITv2 Minimac3 
Sanger Imputation Server 1000GP3 SIS-1000GP3 ShapeITv2 PBWT 
Sanger Imputation Server AGR** SIS-AGR ShapeITv2 PBWT 
* CAAPA: Consortium on Asthma among African-ancestry Populations in the Americas 
**AGR: African Genome Resource 
 PBWT: Positional Burrows-Wheeler Transformation 
 
For each chromosome, a .samples and .haps file is produced following the haplotype phasing 
step. The .samples file is similar to the PLINK fam file in that it contains seven columns 
specifying the Individual ID in two columns, a column specifying the proportion of missing 
data, a paternal and maternal ID, “sex”, and phenotype. The .haps file is a tab-delimited file in 
SNP-major format where each line contains a chromosome number, SNP ID, SNP position, 
encoding for allele A, and encoding for allele B.  
 
                                                 
1 http://mathgen.stats.ox.ac.uk/genetics_software/shapeit/shapeit.html#gettingstarted 
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IMPUTE21 version 2.3.2 (Howie et al. 2009) was used for the imputation of 1000GP3 SNP 
markers into the study dataset. IMPUTE2 describes Panel 0 as being the phased reference 
haplotypes, and Panel 2 as being the phased study haplotypes. The genetic map corresponding 
to the chromosome being imputed was used as the source of genetic recombination rates2. 
IMPUTE2 documentation recommends dividing each chromosome into approximately 5 Mb 
pair chunks. Thus, for each chromosome, the last base pair position was divided by 5 Mb in 
order to determine how many chunks needed to be specified per chromosome. The default 
buffer region of 250 kb was used to include a specified number of SNPs on each side of the 
analysis region using the -int flag. Using a buffer region is recommended by IMPUTE2 as it 
prevents the deterioration of imputation quality near the edges of the chunk being analysed 
(Howie et al. 2009).  
 
The input genotype calling threshold was kept at the default of 0.9 and the MCMC iterations 
were also kept at default values, along with 500 Hidden Markov Model (HMM) states for 
imputation. Imputation using IMPUTE2 produces six files for each chunk of the chromosomes 
imputed. The format of these files are shown in Table 6. A concatenated INFO file was 
generated for each chromosome comprising of the info files per chunk. All genotype files 
obtained per chromosome were concatenated into a single .gen genotype file. 
 
Table 6: Standard output file format from IMPUTE2 
Output file File Format 
genotype file (no 
extension) 
snp_id, rs_id. position, a0, a1, three genotype probabilities for SNP per 
sample 
_info snp_id, rs_id, position, a0, a1, exp_freq_a1, info, certainty, type, 
info_type0, concord_type0, r2_type0 
info_by_sample concord_type0, r2_type0 
_summary A summary of the input files, output files, and processing performed. 
_warnings Any potential errors in the processing 
_samples Individual ID in two columns, missingness proportion, paternal ID, 
maternal ID, “sex”, and phenotype 
 
 
 
                                                 
1 http://mathgen.stats.ox.ac.uk/impute/impute_v2.html  
2 https://mathgen.stats.ox.ac.uk/impute/1000GP_Phase3.html  
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3.4.2.2. Michigan Imputation Server (MIS) workflow 
In preparation for upload to the Michigan Imputation Server1 (Das et al. 2016), genotypes were 
converted to variant call format (VCF) format using PLINK, sorted by ascending chromosomal 
order, and checked for concordance to internal MIS specifications using the checkvcf.py2 
script. As required by the MIS, individual chromosomes were compressed using bgzip and 
indexed using tabix. Both packages are found within BCFtools3. The individual chromosomes 
were uploaded in an unphased state and ShapeITv2 was specified for the haplotype phasing 
step followed by imputation using the MIS’ tool of preference, Minimac3 (Das et al. 2016). 
Per the requirements of the software, Chromosome 23 genotypes in PLINK format were 
converted to be annotated as chromosome “X”.  
 
For the first analysis of the study data on the MIS, phasing was preceded by a QC step in which 
the “mixed” population option was selected when specifying the desired workflow, followed 
by imputation with the 1000GP3 reference panel. In the second independent analysis on the 
MIS, the Consortium on Asthma among African-ancestry Populations in the Americas 
(CAAPA)4 reference panel was specified along with a mandatory selection of the 
“African-American” population for the QC. It is important to note that the CAAPA reference 
does not have reference haplotype data to facilitate imputation of the X chromosome. 
 
3.4.2.3. Sanger Imputation Server (SIS) workflow 
In contrast to the MIS, the SIS5 required a single concatenated and compressed file in VCF 
format. As advised on the SIS help page, a file check was performed on the concatenated VCF 
file using the BCFtools norm -ce flag to ensure that the format met the specifications required 
by the SIS. The SIS strictly does not accept a VCF file failing on the alignment to the human 
reference human_g1k_v37.fasta6 and thus if errors were returned, the fixref plugin available 
from BCFtools was used. Haplotype phasing was performed on the server using ShapeIT2, 
followed by genotype imputation of the available reference panels using the Positional 
Burrows-Wheeler Transformation (PBWT) algorithm (Durbin 2014). The first analysis of the 
                                                 
1 https://imputationserver.sph.umich.edu/start.html#!pages/home  
2 https://github.com/zhanxw/checkVCF 
3 https://github.com/samtools/bcftools/releases/download/1.9/bcftools-1.9.tar.bz2 
4 https://www.caapa-project.org/  
5 https://imputation.sanger.ac.uk/  
6 ftp://ftp.ncbi.nlm.nih.gov/1000genomes/ftp/technical/.../human_g1k_v37.fasta.gz 
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study dataset on the SIS was performed using the 1000GP3 reference panel and the second 
independent imputation made use of the African Genome Resource (AGR) reference panel. 
 
 Selection of high-quality imputed genotype data 
Both the IH workflow using IMPUTE2, and the SIS workflows using the PBWT algorithm 
produce an INFO metric, while the MIS workflow using Minimac3 produces an r-squared 
(Rsq) quality metric. Both quality metrics are an estimation of the squared correlation between 
the true, unobserved genotypes, and the imputed genotypes (Browning and Browning 2009). 
The quality metric ranges from 0 to 1, where values near 1 indicate a high certainty of the 
imputed SNP whereas a value near 0 is a SNP imputed with low certainty. Negative values 
indicate high uncertainty in the imputation and a value of -1 is assigned when the metric cannot 
be calculated for a particular marker (Marchini and Howie 2010). 
 
For each of the imputation analyses, the INFO or Rsq values were extracted for all SNPs and 
the mean quality scores were calculated per MAF bin specified as 0-5%, 5-10%, 10-20%, 
20-30%, 30-40%, and 40-50%. In the case of the SIS, the MAF needed to first be calculated 
using VCFtools1. There is no universal cut-off for filtering on the quality score metric, but 
generally a value between 0.3 and 0.5 is an accepted cut-off (Marchini and Howie 2010). Thus, 
SNPs with an INFO or Rsq value greater than 0.45 were selected for calculating SNP density 
for each workflow. Plots were also generated to compare imputation quality scores across the 
defined MAF bins. 
 
3.5. Perform an association analysis using high-quality imputed host genotype 
data and M. tb superclade data 
The final step in the method was to perform an association analysis using the patient genotype 
and infecting M. tb data. To do so, imputed genotypes were assessed to extract only SNPs 
imputed with high certainty and to determine which reference panel imputed the study dataset 
with the highest quality. The association analysis was then performed using a multinomial 
logistic regression framework implemented in SNPTest.  
 
                                                 
1 http://vcftools.sourceforge.net/  
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 Preparation of genotypes: Post-imputation QC 
The dataset, which had the highest imputation scores per MAF bin, was filtered to exclude 
monomorphic variants by selecting dosage values greater than zero and less than two. SNPs 
with a quality score of greater than 0.45 were prioritised for the association analysis and filtered 
iteratively for a maximum of 10% individual genotype missingness, 2% SNP genotype 
missingness, and 5% SNP MAF using PLINK. Related individuals identified prior to 
imputation were removed followed by a second round of iterative filters for SNP- and sample 
missingness and MAF. Samples which were M. tb clade-matched were extracted from the 
remaining samples which had passed all QC filters. 
 
If the IH dataset in gen/sample format was selected as the best dataset, the first step was to 
obtain a list of SNPs with high quality. To do so, the concatenated INFO file for each 
chromosome was assessed in R to obtain the subset of all the SNPS from which monomorphic 
SNPs and INDELS had been removed, as well as SNPs not meeting the INFO score cut-off of 
0.45. Thereafter, the genotype file for each chromosome was filtered using the subset mode in 
GTOOL version 0.7.51 to retain their corresponding SNPs of high quality.  
 
The filtered genotype files were then merged into a single genotype file using the merge mode 
in GTOOL. The merged genotype and sample files were copied, and the copy was converted 
to PLINK PED/MAP format using the -G flag in GTOOL, incorporating a genotype calling 
threshold of 0.7. Following conversion of the PLINK PED/MAP file to BED/BIM/FAM 
format, the PLINK genotype files were filtered iteratively for a maximum of 10% individual 
genotype missingness, 2% SNP genotype missingness, and 5% SNP MAF using PLINK. 
Related individuals identified prior to imputation were removed followed by a second round 
of iterative filters for SNP- and sample missingness and MAF. Trailing whitespace was 
removed from the .gen file to meet the column specifications of SNPTEST2 v2.5.2 (Marchini 
2010) and samples which were M. tb clade-matched were extracted from the remaining samples 
which had passed all QC filters. 
 
                                                 
1 http://www.well.ox.ac.uk/~cfreeman/software/gwas/gtool.html 
2 https://mathgen.stats.ox.ac.uk/genetics_software/snptest/snptest.html  
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 Preparation of covariables file 
All available covariables were obtained for the cohort under study. These included, where 
available, sex, and age at time of active TB and subsequent recruitment into the study. The first 
sex-specific GWAS for TB was recently performed, and although no genome-wide significant 
associations were detected, the results of the study showed strong evidence of possible 
sex-specific associations for risk of developing TB (Schurz et al. 2018). In light of this finding, 
we found it critical to include sex as a covariable in this analysis to reduce the risk of bias in 
the association test. 
As an individual ages, so does one’s general immunity decrease, and subsequently, 
susceptibility to infectious illnesses, including TB, increases (reviewed in Wang 2012). Thus, 
to mitigate the bias of age influencing the association analysis, age at the time of TB illness 
and recruitment into the study was included as a covariable.  
 
To correct for differences in ethnicity amongst participants, either ancestry proportions or 
principal components were calculated and included as covariables. SNPTEST is unable to 
include covariables when the variance in the values provided is “too small” as indicated here 
https://www.jiscmail.ac.uk/cgi-bin/webadmin?A2=oxstatgen;f8f2270b.1207 . As SNPTEST is 
still under development, it has not yet been established, or recorded in the software manual, to 
what degree of variance covariable data will not be accepted for inclusion in the logistic 
regression. For developing the method, it was established through trial and error that if the 
variance was below 0.001, these covariables could not be included. Additionally, for any 
samples where any of the covariables were not available, the samples were removed and not 
included in the regression analysis. 
 
 Multinomial logistic regression 
For the association analysis, SNPTEST was used to perform the multinomial logistic regression 
(MLR) analysis using an additive genetic model. As opposed to a linear regression model 
which assesses the relationship between a continuous dependent (response) variable and the 
independent (predictor) variable(s), a standard logistic regression is performed when the 
dependent variable is dichotomous. An extension of the standard logistic regression, the 
multinomial logistic regression, is appropriate for testing the relationship between one 
independent variable (e.g. individual SNP genotypes) and the dependent variable which has 
more than two levels (e.g. multiple clades or superclades of M. tb). This method also allows 
Stellenbosch University  https://scholar.sun.ac.za
   
 
 
 
48 
for the adjustment of potential confounding factors. For both cohorts investigated in this study, 
we were able to adjust for potential confounders such as ethnicity, sex, and age by including 
these as covariables in the model. 
 
SNPTEST tests for association using frequentist statistical methods. Two discrete variables, 
namely sex and superclade, as well as continuous variables, namely age at TB onset and 
ancestry proportions or principal components were included in the analysis. The phenotype 
tested was specified as the M. tb superclade. Thus, the MLR model specified was the 
occurrence of the M. tb superclade as a function of the baseline covariables given, as well as 
the genotypes supplied. The standard genome-wide significance cut-off of alpha = 5 x 10-8 was 
used when reporting significance of SNPs (The International HapMap Consortium 2005; Pe’er 
et al. 2008). Odd’s ratios for the multiple phenotypes tested are calculated against a baseline 
phenotype by setting the odds of that phenotype occurring, given the genotype, to 1. A baseline 
phenotype may be specified by the user, or it will be determined internally by taking the first 
phenotype to appear alphabetically. For this study, the baseline phenotype was specified as the 
dominant superclade in the cohort, or a common superclade of intermediate frequency if more 
than one cohort is being studied. 
 
SNPs with a Likelihood Ratio Threshold (LRT) p-value of less than 5 x 10-4 were selected and 
analysed in R and odds ratios were calculated from the beta values generated by SNPTEST. 
SNPs with a standard error greater than 1.5 for their odds ratios were excluded and SNPs with 
an LRT p-value less than 1 x 10-6 were prioritised for further investigation. As this was a 
methods-development study, these thresholds were selected pragmatically for the completion 
of the method. 
 
 Gene annotations of selected SNPs 
The Variant Effect Predictor (VEP) Tool (McLaren et al. 2016) was used to retrieve gene 
annotations for the SNPs of interest. 
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CHAPTER FOUR 
4. Results 
4.1. Participant recruitment and sample collection 
 Participant recruitment  
A total of 947 study participants were recruited for the SAC cohort, while 3 311 participants 
were recruited for the Ghanaian cohort. All participants provided blood and sputum samples 
for SNP genotyping, and M. tb isolate identification, respectively. 
 
 Sample processing 
4.1.2.1. SNP genotyping 
4.1.2.1.1. SAC cohort 
A total of 947 participants recruited into the study were genotyped for 500 000 SNPs on the 
Affymetrix 500K SNP array. Of the 500 000 SNPs on the array, 397 337 (79.4%) were 
successfully genotyped for all samples. Of the 947 samples genotyped, 853 were TB cases and 
516 were male. For the subset of cases used in this cohort, 55% of the individuals recruited 
were male (Table 7). Ancestry proportions for the five-way admixed SAC cohort genotyped 
on the Affymetrix array indicated that the study participants were predominantly of isiXhosa 
ancestry (33%), followed by Khomani (31%), European (16%), South-Asian (13%), and 
East-Asian ancestry (7%) (Daya et al. 2013; Chimusa et al. 2013; De Wit et al. 2010). 
 
Table 7: Summary of patient recruitment for the SAC and Ghanaian cohorts 
 SAC Ghana 
Cases 853 1 359 
Male 516 2 087 
Female 431 1 224 
Cases + Male 469 (55%) 933 (69%) 
Cases + Female 384 (45%) 426 (31%) 
Total number of participants  947 3 311 
Total number of variants 397 337 783 338 
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4.1.2.1.2. Ghanaian cohort 
For the Ghanaian cohort, 3 311 participants were genotyped for 906 600 SNPs on the 
Affymetrix SNP 6.0 array. Of the available SNPs, all samples were successfully genotyped for 
783 338 variants. Of the samples included in this study, 1 359 were TB cases and 69% of the 
participants were male (Table 7). PCA revealed that the study participants had contributing 
ethnicities from the Akan, Ga-Adangbe, Exe, and several other ethnic groups in northern Ghana 
(Thye et al. 2012). 
 
4.1.2.2. Spoligotyping // IS6110 RFLP records 
4.1.2.2.1. SAC cohort 
A Patients-Strain database (PS) was created by linking each patient’s record in the Patients 
database to its corresponding M. tb isolate record from the Strain database. The PS database 
could not be directly linked to the genotyping file as there were no overlapping columns 
between the two databases (Table 4). Thus, using the Case ID in an intermediary file, Individual 
IDs from the FAM file were matched to the Patient IDs in the PS database. The Individual ID 
was consistent with the Sample ID column in the linking file and yielded a dataset of 527 
genotyped study participants matched on Sample ID to 609 M. tb records (Figure 7).  
 
4.1.2.2.2. Ghanaian cohort 
Of the 3 311 TB study participants genotyped, 1 318 of the 1 359 cases had corresponding 
M. tb clade information and no samples were found to be genotyped more than once.  
 
4.2. Defining M. tb clades and superclades 
Using the SNP-based phylogeny for M. tb (Dippenaar 2014), M. tb clades were grouped into 
superclades by clustering closely-related clades near a point of divergence as indicated by the 
dashed red line and coloured dots in Figure 6. This point of divergence was chosen to reduce 
the number of clades of low frequency into superclades with higher frequency.  
 
Clustering based on the phylogenetic tree reduced 12 distinct clades into five closely-related 
superclades. The East-African Indian (EAI) and M. africanum clades (green bracket) merged 
into the “EAI_afri” superclade, as did the CAS and Beijing clades into the “BeijingCAS” (red 
bracket). The Low-copy Clades (LCC), Pre-Haarlem, Haarlem-like, and Haarlem clades 
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merged into one superclade designated as “HaarlemsLCC” (orange bracket), while the Quebec, 
LAM, T, and Lineage 7 clades remained unchanged and are indicated by black brackets Figure 
6). 
 
The SAC cohort contained seven of the 12 clades on the phylogenetic tree, namely Beijing, 
CAS (represented as CAS1 in the Strain database), Haarlem, Haarlem-Like, LCC, T and 
Quebec. A clade denoted as “Other” was also present in the SAC cohort but does not appear 
on the phylogenetic tree (Figure 6) and consisted of 35 “Family” classifications, and thus was 
kept as a distinct member during the grouping strategy. The “T” clade was excluded from 
subsequent analysis due to low frequency in the cohort after clustering into superclades. 
 
The Ghanaian cohort contained 12 clade annotations obtained from spoligotyping. The afri-181 
and afri-438 clades were represented by M. africanum on the phylogenetic tree and were 
subsequently grouped with EAI at the point of divergence, and named as the EAI_afri 
superclade. Beijing and CAS were merged, as were Haarlem and X into a “HaarlemX” 
superclade. T and U clades were clustered as indicated on Figure 6. The “Ghana-2” clade was 
kept as a distinct superclade, while LAM and CAM were grouped based on the similarity in 
their spoligotyping patterns illustrated in Stucki et al. 2016. 
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Figure 6: Clustering of M. tb clades produced seven distinct superclades. 
Stellenbosch University  https://scholar.sun.ac.za
   
 
 
 
53 
4.3. Preliminary assessment of paired data 
 Genotype QC 
4.3.1.1. SAC cohort 
For genotyping QC, a total of 397 337 variants and 947 individuals were loaded from the 
genotype files in PLINK format. Three hundred and eighty one variants were excluded from 
the genotyping data set because they had no assigned chromosome or base pair position. 
Additionally, iterations of the filters for individual missingness (--mind), SNP missingness 
(--geno), and MAF (--maf) removed 11 individuals, 96 876 variants, and 31 516 variants from 
the dataset, respectively.  
 
The “sex” check flagged 14 “problem” individuals in which either the “sex” in the PED file 
did not match the genotypes in the MAP file, or ambiguity was detected between the SNP data 
and pedigree data, and were subsequently removed from the dataset. Duplicate samples were 
identified and a pairwise analysis of Identity-By-Descent (IBD) showed that the dataset 
consisted of a number of related individuals. A pi-HAT threshold of 0.125 was chosen to filter 
at the level of first-cousin relatedness, resulting in 189 pairs of related individuals. In order to 
obtain the maximum set of unrelated individuals, the Perl script by Yekai Xiong identified 137 
individuals who needed to be removed. The remaining 785 individuals were filtered 
for --mind/--geno/--maf resulting in 4 273 variants being filtered out, and leaving 264 291 
variants for 785 unrelated individuals. The test for excess genotyping heterozygosity resulted 
in four individuals being removed, followed by the removal of 58 variants not meeting the 
MAF threshold, leaving 781 individuals and 264 233 variants.  
 
Using a file containing the Sample IDs for the 525 participants having first infection records 
in the PS database, the genotype dataset of 781 unrelated individuals was filtered to extract 
only the genotypes of those participants having M. tb clade information. From this subset of 
samples passing QC, 439 of the 525 individuals having a record for their first infection were 
retained and assessed using PCA. It is likely due to the iterative filters for poor genotyping, 
sample missingness, and relatedness, that individuals having clade information were removed. 
 
4.3.1.2. Ghanaian cohort 
For the Ghanaian cohort, genotype data was available in PLINK format for a total of 783 338 
variants for 3 311 samples. No variants required annotation of chromosome number or base 
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pair position. Samples were filtered iteratively for 10% individual genotype missingness, 2% 
SNP genotype missingness and 5% MAF, resulting in no individuals, 73 322 variants, and 
32 711 variants being removed, respectively. The “sex” check removed 24 samples, while an 
additional 93 samples were identified as being closely related to at least one other sample in 
the cohort. A test for excess heterozygosity resulted in an additional 47 samples being removed, 
leaving a dataset consisting of 3 147 samples and 677 305 variants. Of the 1 315 clade-matched 
samples, 1 273 samples were present in the dataset passing QC and were analysed using PCA. 
 
 M. tb database quality control 
4.3.2.1. SAC cohort 
The first QC measure involved assessing the dataframe for any duplicated genotypes based on 
the number of Sample IDs matched to strain information in the database. This analysis showed 
that three individuals were genotyped twice (Figure 7). Genotyping quality scores for each 
duplicated genotype were examined and the sample genotyped with the poorer quality score 
was excluded from further analysis. 
 
 
Figure 7: Filtering of Patient-Strain database yielded 525 genotyped study participants from 
the SAC cohort with information for the M. tb infection. 
Patients database (P) 
n = 3937
M. tb. database (S)
n = 4583 
SAC Affymetrix
n = 947
PS
n = 985
527 604
609527
PS_SAC
525 602
Remove duplicate records
Remove records for low frequency 
M.tb. superclades
No. of RecordsNo. of Patients
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The second QC measure was to identify study participants having an incorrect infection 
number assigned to their record(s). This filter identified five individuals with incorrect 
infection numbers assigned. Generating a table of the number of records per Patient ID showed 
that a total of 459 participants had only one M. tb record, while one individual had four records 
in the PS dataframe (Table 8). 
 
Table 8: Number of genotyped study participants with single- and multiple infections in the 
database 
Number of records per Patient ID in PS database Number of Study participants 
1 459 
2 60 
3 7 
4 1 
Total number of study participants 527 
 
4.3.2.2. Ghanaian cohort  
For the Ghanaian cohort, no infection number was provided with this dataset, and thus all 
records were considered as the first infection for participants in this cohort. 
 
 Derive M. tb distributions  
4.3.3.1. SAC cohort 
Frequency distributions for clades and superclades were derived for a number of subsets of the 
genotyped and clade-matched study participants. M. tb clade- and superclade distributions for 
the first recorded infection in the SAC cohort are shown in Figure 8, and Figure 9, respectively. 
The distribution of M. tb clades and superclades for the second recorded infection is shown in 
Figure 10, and Figure 11, respectively. The first recorded infection in the database was 
dominated by the LAM clade and closely followed by Beijing, whereas the second infection 
was dominated by the Beijing clade and followed by LAM. There were no cases of 
HaarlemLike reported for the second infection. The frequency distribution of superclades 
showed similar frequencies for LAM, BeijingCAS1, and HaarlemsLCC for the first recorded 
infection (Figure 9). As seen in Figure 9, LAM dominated the superclade distribution in the 
first infection, but was only third in abundance in the second infection, dominated by the 
BeijingCAS1 superclade (Figure 11). 
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The M. tb clade- and superclade distribution amongst participants having one-, and two 
infections in the database is shown in Figure 31. LAM, followed by the Beijing clade 
dominated the frequency distribution for participants having only one recorded infection in the 
database. In contrast, Beijing was followed by LAM in the clade distribution amongst 
participants with two infections recorded in the database, while the distribution of the 
remaining six clades followed the same pattern in both subsets (Figure 31 A and C). After 
grouping the clades into superclades, the frequency distribution of LAM, HaarlemsLCC, and 
BeijingCAS1 dominated both subsets of participants having one- and two recorded infections 
while Other and Quebec superclades were in least abundance (Figure 31 B and D). 
 
For the participants having two infections, an interesting observation was made when 
stratifying the 120 records by infection number. The dominant clade for the first of two 
infections was LAM followed by Beijing and Haarlem (Figure 32 A in 7.1), whereas for the 
same cohort of 60 participants, records for the second of two infections were dominated by 
Beijing, followed by LCC and LAM (Figure 32 C). Frequency distributions for the same cohort 
based on superclade showed a combination of both distributions (Figure 32 B and D) where 
the first infection of two was dominated by the HaarlemsLCC superclade, followed by LAM, 
and then Beijing. 
 
4.3.3.2. Ghanaian cohort 
Frequency distributions were derived for clade and superclade definitions used in this cohort 
and are shown in Figure 12, and Figure 13, respectively. After grouping the clades into 
superclade categories, the EAI_afri and LAM_CAM superclades dominated the distribution in 
the cohort with both groupings having more than 400 records (Figure 13). The Haarlem_X, 
and T_U superclades had a frequency of approximately 160, and 250 in the cohort, 
respectively, while the BeijingCAS and Ghana-2 superclades were in least abundance (Figure 
13). All M. tb clade information available for this cohort was for one recorded infection; no 
data were available regarding previous infections or multiple infections. 
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Figure 8: Frequency distributions of M. tb Clades for the First infection records (n = 525) in the SAC cohort 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
   
 
 
 
58 
 
Figure 9: Frequency distributions of M. tb Superclades for the First infection records (n = 525) in the SAC cohort 
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Figure 10: Frequency distributions of M. tb Clades for the Second infection records (n = 60) in the SAC cohort 
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Figure 11: Frequency distributions of M. tb Superclades for the Second infection records (n = 60) in the SAC cohort 
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Figure 12: Frequency distributions of M. tb Clades (n= 1 318) in the Ghanaian cohort 
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Figure 13: Frequency distributions of M. tb Superclades (n= 1 318) in the Ghanaian cohort 
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 PCA of first recorded infection 
4.3.4.1. SAC cohort 
After loading the compressed PLINK files for PCA, 7 072 non-autosomal SNPs were excluded, 
and the working space consisted of 439 samples and 257 161 SNPs. A scree plot consisting of 
32 eigenvalues was plotted (Figure 14) and showed that 10% of the variance in the data could 
be explained by the principal components generated. A cut-off was chosen at the point of 
Principal Component (PC) 3, as the variation in the data became least explicable after the third 
PCPC (Figure 14). 
 
Clade, and superclade distributions and PCA plots for the 439 samples that passed genotyping 
QC were generated and are shown in Figure 15 and Figure 16, respectively. The overlay of 
either clade or superclade data for the first recorded infection showed no separation of the 
genotypes into distinct clusters based on M. tb designations. Clade frequency distributions for 
the SAC cohort showed that the first recorded infection was mostly caused by LAM and that 
there were few infections caused by CAS1 or HaarlemLike (Figure 15 A). No extreme outliers 
were evident from the PCAs generated for the SAC cohort. 
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Figure 14: Scree plot for the First recorded infection in the SAC cohort passing genotyping 
QC (n = 439). 
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Figure 15: Clade distribution (A) and PCA of 439 genotyping records with the first infection recorded in the SAC cohort. Figures B, C, and D 
show PC1 and PC2, PC2 and PC3, and PC1 and PC3, respectively. 
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Figure 16: Superclade distribution (A) and PCA of 439 genotyping records with the first infection recorded in the SAC cohort. Figures B, C, and 
D show PC1 and PC2, PC2 and PC3, and PC1 and PC3, respectively. 
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4.3.4.2. Ghanaian cohort 
No non-autosomal SNPs were detected and thus the working space consisted of 1 273 samples 
having 677 405 variants. A scree plot consisting of 32 eigenvalues was generated and showed 
that a very small proportion (2%) of the observed variance could be explained by the first three 
principal components generated (Figure 17). PC plots were generated for the first three 
principal components. The clade and superclade distributions for the 1 273 samples passing the 
QC filters was determined and is shown in Figure 18 A and Figure 19 A. As with the SAC 
dataset, the overlay of clade and superclade information showed no separation of the genotypes 
into distinct clusters as shown in the PC plots in Figure 18 and Figure 19. The LAMCAM 
superclade dominated the first recorded infection, while the Ghana-2 superclade was least 
abundant in this cohort. Furthermore, no extreme outliers were evident from the PCA.
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Figure 17: Scree plot for the First recorded infection in the Ghanaian cohort passing genotyping QC (n = 1 273). The PCA was able to account 
for a maximum of 2% of the variation in the patient genotypes. 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
   
 
 
 
69 
 
 
Figure 18: Clade distribution (A) and PCA of 1 273 genotyping records with the first infection recorded for the Ghanaian cohort. Figures B, C, 
and D show PC1 and PC2, PC1 and PC3, and PC2 and PC3, respectively. 
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Figure 19: Superclade distribution (A) and PCA of 1 273 genotyping records with the first infection recorded for the Ghanaian cohort. Figures B, 
C, and D show PC1 and PC2, PC2 and PC3, and PC1 and PC3, respectively. 
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4.4. Generate high-quality imputed genotype data 
 Modified Data QC for Imputation 
To prepare the data for imputation, a modified QC method was designed as shown in Figure 5. 
General genotyping QC steps were modified to include the updating of variants lacking base 
pair or chromosome information using the dbSNP database, and checking for SNP and strand 
flips using Genotype Harmonizer. These steps ensured that the data being imputed were 
correctly aligned to the most widely-used reference panel, the 1000GP3, and that the maximum 
number of the originally genotyped variants were assessed in the genotyping QC steps that 
followed. The results of this QC method are shown in Figure 20 for the SAC dataset and Figure 
21 for the Ghanaian dataset.  
 
The initial SAC dataset comprised of 947 participants genotyped for 397 337 variants. After 
pre-imputation QC, imputation, and post-imputation QC, the SAC dataset consisted of 445 
clade-matched participants with 7 145 406 variants after imputation with the AGR reference 
panel yielding the highest quality imputed genotypes (Figure 20).These 7 145 406 variants for 
445 participants were the evaluated for association using a multinomial logistic regression. 
 
The Ghanaian dataset comprised of 3 311 participants with genotypes for 783 338 variants. 
The 1000GP3 reference panel imputed using our In-House method yielded the highest quality 
imputed genotypes across several MAF bins. After QC, the dataset consisted of 5 275 890 
variants for 1 272 clade-matched individuals, which were then assessed for association using a 
multinomial logistic regression (Figure 21). The subsections to follow describe the filtering of 
both datasets in greater detail. 
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Figure 20: Results of filtering the SAC dataset using the modified genotyping QC method prior 
to imputation 
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Figure 21: Results of filtering the Ghana dataset using the modified genotyping QC method 
prior to imputation 
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4.4.1.1. Update variants lacking chromosome or base pair position 
information 
4.4.1.1.1. SAC cohort 
A total of 381 SNPs from the genotype files did not have a chromosome or base pair position 
assigned. Instead of immediately excluding these SNPs, as was done in 3.3.1, chromosome 
number and base pair positions were retrieved, where possible, using the 1000GP3 reference 
in conjunction with validation of the information in the dbSNP database (Figure 20). The 
percentage overlap between the study data (397 046 SNPs) and the 1000GP3 was calculated to 
be 97.26 %.  
 
Of the 381 SNPs, 91 were found in the 1000GP3. All 91 SNPs found in the 1000GP3 were also 
found in the dbSNP database. However, one SNP, rs41516445 located on chromosome 5 was 
flagged in dbSNP as not being validated by laboratory methods, and was thus excluded from 
the list of SNPs to update. The 90 variants for which chromosome number and base pair 
position could be retrieved in the 1000GP3, and were verified in dbSNP, were successfully 
updated in the PLINK genotype files. The 291 SNPs for which information could not be 
updated were then written to file and excluded using PLINK, yielding a BIM file containing 
397 046 variants with a genotyping rate of 98.6 % for 947 samples (Figure 22). 
 
4.4.1.1.2. Ghanaian cohort 
No variants in the Ghanaian genotype files lacked chromosome or base pair information. The 
percentage overlap between the genotype data (783 338 SNPs) and the 1000GP3 reference 
panel was calculated to be 99.48 %. 
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Figure 22: Schema of SNP annotation update workflow for SAC cohort 
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4.4.1.2. Examine the data for ambiguity in alignment to reference data 
4.4.1.2.1. SAC cohort 
A total of 947 samples with 397 046 SNPs were analysed using Genotype Harmonizer. Of the 
SNPs loaded, the first iteration aligned 329 524 non-A/T and non-G/C (i.e. non-ambiguous) 
SNPs, and swapped 317 SNPs to match the allele order of the 1000GP3. A total of 21 out of 
63 429 ambiguous SNPs were swapped based on their LD patterns. A total of 40 881 variants 
were excluded during the alignment phase: 2 786 due to the study variant being found in the 
reference dataset, but the alleles not being comparable, and 38 095 variants being excluded due 
to there not being enough non-ambiguous SNPs in LD to assess the strand based on LD. No 
non-biallelic SNPs were found, leaving 947 samples with 356 165 variants. 
 
4.4.1.2.2. Ghanaian cohort 
The genotype files of 3 311 samples with 783 338 SNPs were loaded into Genotype 
Harmonizer. Of the SNPs loaded, the first iteration aligned 656 121 non-A/T and non-G/C 
SNPs, and swapped 376 SNPs to match the allele order of the 1000GP3. A total of 36 out of 
118 868 ambiguous SNPs were swapped based on their LD patterns, and a total of 70 115 
variants were excluded during the alignment phase. No non-biallelic SNPs were found, leaving 
3 311 samples with 713 223 variants.  
 
4.4.1.3. Genotype QC 
4.4.1.3.1. SAC cohort 
A total of 28 individuals were removed - 11 due to individual genotype missingness, 13 due to 
ambiguity in the “sex” assignment, and 4 due to excess heterozygosity in their genotypes. 
Furthermore, 116 553 variants were removed during the iterative process of filtering for SNP 
missingness and MAF, leaving a dataset consisting of 919 individuals and 239 612 variants 
that passed QC with a genotyping rate of 99.39 %. 
 
4.4.1.3.2. Ghanaian cohort 
A total of 72 individuals were removed - 24 due to ambiguity in the “sex” assignment, and 48 
individuals removed due to excess heterozygosity. Furthermore, 95 814 variants were removed 
during the iterative process of filtering for SNPSNP missingness and MAF, leaving a dataset 
consisting of 3 239 individuals and 617 409 variants with a genotyping rate of 99.39 %. 
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 Data preparation, Haplotype phasing, and Genotype imputation 
4.4.2.1. In-house (IH) workflow 
No additional data preparation was required for the IH workflow using ShapeIT2 and 
IMPUTE2. For the IH workflow, a data summary is not produced as a standard output for 
imputation using IMPUTE2 software.  
 
4.4.2.2. Michigan Imputation Server workflow 
The MIS produces a data summary as shown for both cohorts in Table 9. 
Table 9: Summary of data pre-processing on the Michigan Imputation Server 
 SAC Ghana 
 MIS-
1000GP3 
MIS-
CAAPA 
MIS-
1000GP3 
MIS- 
CAAPA 
Chromosomes 1-23 1-22 1-22 1-22 
Samples IN 919 919 3 239 3 239 
No. of SNPs IN 239 612 233 309 617 409 617 409 
No. “sex” detected and 
therefore filtered:  
3 0 0 0 
Alternative allele frequency > 
0.5 sites: 
166 0 0 0 
Reference Overlap 99.49 97.94 99.55 97.23 
Match 164 643 153 863 420 805 412 495 
Allele Switch 74 116 68 912 176 073 172 432 
Strand flip 1 0 0 0 
Strand flip and allele switch 0 0 1 0 
A/T, C/G genotypes 6 090 5 723 15 683 15 330 
Filtered sites:     
Filter flag set 0 0 0 0 
Invalid alleles 0 0 0 0 
Duplicated sites 0 0 0 0 
NonSNP sites 0 0 0 0 
Monomorphic sites 0 0 0 0 
Allele mismatch 54 8 2 051 25 
SNPs call rate < 90%: 0 0 0 0 
Excluded sites in total: 55 8 2 052 25 
Remaining sites in total (before 
imputation) 
239 477 228 498 
 
612 561 600 257 
 
Samples OUT 916 916 3 239 3 239 
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4.4.2.3. Sanger Imputation Server workflow 
4.4.2.3.1. SAC cohort 
The Sanger Imputation Server (SIS) does not allow for any mismatches between the reference 
dataset and the study dataset. Per the recommendations of the tool, the first analysis of the 
dataset through the fixref plugin indicated that 32.7% of the SNPs were mismatched to the 
human reference genome (human_g1k_v37.fasta). After aligning alleles to the human 
reference, a second run of the fixref plugin indicated 993 SNPs (0.4%) in the study dataset 
were unresolved. A third alignment of the study alleles to the human reference, flagged 406 
mismatch SNPs (0.2%). These 406 SNPs were removed from the dataset, leaving a total of 
232 902 SNPs completely aligned to the orientation of the reference dataset. This data was 
uploaded to the SIS for imputation with the 1000GP3, and AGR reference panels. 
 
4.4.2.3.2. Ghanaian cohort 
The first analysis of the dataset through the fixref plugin reported that 31.4% of the SNPs were 
mismatched to the human reference (human_g1k_v37.fasta). After aligning SNPs, a second 
run of the plugin indicated 0.4% of the SNPs in the study dataset were mismatched to the 
reference. A third attempt was made to align the alleles but when the number of reference 
mismatches remained unchanged, 2 453 SNPs were removed from the dataset, leaving a total 
of 614 676 SNPs completely aligned to the reference dataset. This data was uploaded to the 
SIS for imputation in two independent analyses: one using the 1000GP3 reference panel, and 
the second using the AGR reference panel.  
 
 Selection of high-quality imputed genotype data 
4.4.3.1. Comparison of SNP density obtained from each workflow 
SNP densities were calculated for the proportion of SNPs with a quality score metric greater 
than 0.45. For the SAC cohort, the SIS workflow using the AGR resource imputed the highest 
proportion of SNPs (Table 10, Figure 23 E, Figure 24 D), whereas for the Ghanaian cohort, 
the MIS workflow using the CAAPA resource imputed the greatest proportion of SNPs with a 
quality metric greater than 0.45 (Table 10, Figure 25 D, Figure 26 D). 
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Table 10: Percentage proportion of SNPs with a quality metric greater than 0.45 
 SAC GHANA 
 Chr 1 Chr X Chr 1 Chr 22 
IH-1000GP31 39 29 38 39 
MIS-1000GP32 32 18 49 45 
MIS-CAAPA3 22 - 56 50 
SIS-1000GP34 36 32 41 40 
SIS-AGR5 43 40 38 36 
     
1IH-1000GP3: In-House workflow using 1000GP3 reference panel 
2MIS-1000GP3: Michigan Imputation Server workflow using 1000GP3 reference panel 
3MIS-CAAPA: Michigan Imputation Server workflow using CAAPA reference panel 
4SIS-1000GP3: Sanger Imputation Server workflow using 1000GP3 reference panel 
5SIS-AGR: Sanger Imputation Server workflow using AGR reference panel 
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4.4.3.1.1. SAC cohort 
 
Figure 23: SNP Density plots for Chromosome 1 of the SAC cohort post imputation using the 
five workflows: (A)IH with 1000GP3, (B)MIS with 1000GP3, (C)SIS with 1000GP3, (D)MIS 
with CAAPA, and (E)SIS with AGR 
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Figure 24: SNP Density plots for Chromosome X of the SAC cohort post imputation using 
four workflows: (A)IH with 1000GP3, (B)SIS with 1000GP3, (C)MIS with 1000GP3, (D)SIS 
with AGR. The MIS CAAPA workflow does not facilitate imputation of the X chromosome. 
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4.4.3.1.2. Ghanaian cohort 
 
Figure 25: SNP Density plots for Chromosome 1 of the Ghanaian cohort post imputation using 
the five workflows: (A)IH with 1000GP3, (B)MIS with 1000GP3, (C)SIS with 1000GP3, 
(D)MIS with CAAPA, (E)SIS with AGR. 
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Figure 26: SNP density plots for Chromosome 22 of the Ghanaian cohort post imputation using 
the five workflows: (A)IH with 1000GP3, (B)MIS with 1000GP3, (C)SIS with 1000GP3, 
(D)MIS with CAAPA, (E)SIS with AGR. 
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4.4.3.2. Comparison of quality scores across MAF bins 
When plotting the median quality scores obtained per MAF bin for each of the five tools, the 
SIS workflow using the AGR resource was confirmed to have produced the highest quality of 
imputed data for the SAC cohort whereas the 1000GP3 reference panel using any of the 
workflows produced the highest quality for the Ghanaian cohort. 
 
4.4.3.2.1. SAC cohort 
For both chromosomes 1 and X, imputation using either the 1000GP3 or the CAAPA resource 
with the MIS performed the worst for the SAC dataset (Figure 27 A and B) with the maximum 
median quality score only reaching 0.82 at a MAF of 50%. In comparison, the SIS-AGR 
workflow outperformed all other workflows, and the result correlated with the AGR imputing 
the highest SNP density for chromosome 1 (Figure 23 E) and chromosome X (Figure 24 E). 
 
4.4.3.2.2. Ghanaian cohort 
For the Ghanaian cohort, despite the CAAPA resource imputing the greatest SNP density 
(Figure 26 D), the IH workflow using the 1000GP3 reference panel imputed the highest quality 
of SNPs per MAF bin but was very closely followed by the other workflows and reference 
panels from the 20-30% MAF bin upwards (Figure 28 A and B). 
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Figure 27: Median quality scores across MAF bins for Chromosome 1 and X for the SAC cohort, using the five workflows for chromosome 1 and 
four workflows for the X chromosome 
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Figure 28: Median quality scores across MAF bins for Chromosome 1 and 22 for the Ghanaian cohort, using the five workflows  
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4.5. Perform an association analysis using high-quality imputed host genotype 
data and M. tb superclade data 
 Preparation of genotypes: Post-imputation QC 
4.5.1.1. SAC cohort 
The data obtained from the SIS, imputed with the AGR reference panel was selected as the 
dataset with the highest imputation quality across all those assessed. After removal of 
monomorphic sites and filtering on an INFO score of 0.45, 28 566 283 SNPs for 919 samples 
remained. After removing the 136 related individuals identified prior to imputation, and 
filtering for SNP- and sample missingness, and MAF, a dataset of 7 145 406 variants for 783 
participants remained. Of the 525 clade-matched participants, 445 were extracted from the 
dataset of samples passing QC and used in the association analysis. 
 
4.5.1.2. Ghanaian cohort 
The In-house dataset, imputed with the 1000GP3 reference panel was selected as the best 
dataset. After filtering out monomorphic SNPs, INDELS, and variants not reaching the INFO 
score cut-off, 25 968 622 SNPs remained for 3 239 samples. After filtering for MAF, SNP- and 
sample missingness, and removal of 93 related individuals identified pre-imputation, the 
dataset comprised of 5 275 890 variants for 1 273 clade-matched samples. One sample was 
removed due to there not being covariable data for that sample. 
 
 Preparation of covariables file 
4.5.2.1. SAC cohort 
For the SAC cohort, the covariables age, “sex”, and ethnicity in the form of ancestry 
proportions were available for all samples. Available ancestry proportions were for the 
European, African, San, South-Asian, and East-Asian ancestries. Of the 445 samples which 
were clade-matched and passed QC after imputation, ancestry proportions were available for 
357 samples as generated previously using the Affymetrix genotype data for this cohort and 
ADMIXTURE software. For the remaining 88 samples, ancestry proportions were obtained 
from a run of ADMIXTURE using genotype data from the MEGA array.  
 
The East-Asian ancestry being the smallest contributing ancestry proportion was not included 
as a covariable in the analysis. Variances were calculated for each of the four remaining 
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ancestry proportions and determined to be 0.027 (San), 0.035 (African), 0.014 (European), and 
0.009 (South Asian). As the variances were greater than the minimum cut-off (determined 
through trial and error) of 0.001, they were included as covariables in the analysis. No 
“missing” proportion was available for this cohort, and thus a column denoting this data as 
“NA” was added to meet the specifications of SNPTEST. 
 
4.5.2.2. Ghanaian cohort 
For the Ghanaian cohort, age, “sex”, and ethnicity in the form of principal components was 
available as covariables. One sample passing QC filters did not have one of the covariables and 
was thus excluded from the dataset leaving 1 272 samples for the association analysis. The 
variance in the PCs provided for the cohort was calculated to be 0.0002 (PC1), 0.0003 (PC2), 
and 0.0004 (PC3) and thus determined to be insufficient for inclusion in the analysis as 
covariables.  
 
 Multinomial logistic regression 
4.5.3.1. SAC cohort 
A multinomial logistic regression was run on the 445 clade-matched samples using SNPTEST 
under an additive model. All results were reported using the LAM superclade as the baseline. 
A total of 4 631 SNPs had an LRT p-value less than 0.0005 and eleven SNPs had an LRT 
p-value less than 1 x 10-6. A single SNP, rs9389610, located on chromosome 6, had a p-value 
of 1.60 x 10-7. Odds ratios are reported in Table 11 and standard errors of the odds ratios are 
shown in Figure 29. 
 
Individuals with the A allele of this SNP were twice as likely to be infected with a member of 
the BeijingCAS1 superclade, than to be infected with either the HaarlemsLCC or LAM 
superclades. Results from the logistic regression at this SNP also reported that individuals with 
the A allele were only slightly more at risk of being infected with a member of the ‘Other’ 
superclade, when compared to the BeijingCAS1 superclade, and were very unlikely to be 
infected with a member of the Quebec superclade. 
 
For the four SNPs located on chromosome 5, individuals with the risk allele were two to three 
times more at risk of being infected with the HaarlemsLCC or BeijingCAS1 superclade as 
compared to the reference LAM superclade. The risk allele also doubled the chances of being 
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infected with the Quebec superclade while halving the risk of being infected with a member of 
the “Other” superclade (Table 11). 
 
 
Figure 29: Standard errors of odds ratios calculated for each superclade against the reference 
LAM superclade for the SAC cohort. 
 
For the six SNPs located on chromosome 17, the risk allele was shown to double the risk of 
being infected with a member of the LAM superclade than with the HaarlemsLCC superclade. 
Individuals with the risk allele of these six SNPs were also equally at risk of being infected 
with a member of the BeijingCAS1 or LAM superclade and were twice as likely to be infected 
with the Other superclade when compared to the BeijingCAS1 superclade (Table 11).
Stellenbosch University  https://scholar.sun.ac.za
   
 
 
 
90 
Table 11: Top 11 SNPs identified by MLR to be associated with different M. tb superclades in the SAC cohort 
Chr SNP ID Reference 
allele 
Risk 
allele 
OR LAM 
(Reference) 
BeijingCAS1 
OR(95%CI) 
HaarlemsLCC 
OR(95%CI) 
Other 
OR(95%CI) 
Quebec 
OR(95%CI) 
LRT_p_valu
e 
5 rs17458866 C T 1 0.34 (0.19-0.61) 0.44 (0.26-0.76) 0.46 (0.23-0.95) 1.99 (1.07-3.68) 10e-07 
5 rs13355101 G A 1 0.31 (0.17-0.57) 0.46 (0.27-0.79) 0.47 (0.23-0.96) 2 (1.08-3.7) 6.43e-07 
5 rs12518239 C A 1 0.29 (0.15-0.56) 0.39 (0.22-0.7) 0.51 (0.25-1.05) 1.91 (1.01-3.62) 9.41e-07 
5 rs28769614 C T 1 0.27 (0.13-0.53) 0.37 (0.2-0.68) 0.48 (0.23-1.01) 1.92 (1-3.66) 3.03e-07 
6 rs9389610 G A 1 2.19 (1.35-3.55) 1.07 (0.64-1.76) 2.78 (1.52-5.08) 0.25 (0.08-0.73) 1.60e-07 
17 rs78022196 G A 1 1.04 (0.6-1.8) 0.59 (0.32-1.09) 1.96 (1.03-3.73) 5.31 (2.44-11.57) 5.13e-07 
17 rs72843143 C T 1 0.98 (0.57-1.69) 0.57 (0.31-1.04) 1.89 (1-3.58) 4.81 (2.26-10.25) 8.18e-07 
17 rs8071332 A G 1 0.94 (0.55-1.6) 0.59 (0.33-1.06) 2.03 (1.08-3.81) 4.77 (2.22-10.28) 6.54e-07 
17 rs10438776 T C 1 0.99 (0.58-1.71) 0.55 (0.3-1.01) 1.94 (1.02-3.69) 4.99 (2.3-10.85) 3.93e-07 
17 rs17682747 G A 1 0.98 (0.57-1.68) 0.56 (0.31-1.03) 1.9 (1.01-3.58) 4.85 (2.27-10.33) 5.93e-07 
17 rs7208461 T C 1 0.94 (0.55-1.61) 0.54 (0.3-0.98) 1.77 (0.94-3.34) 4.68 (2.17-10.1) 8.64e-07 
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4.5.3.2. Ghanaian cohort 
A multinomial logistic regression was run on the 1 272 clade-matched samples using 
SNPTEST under an additive model. All results were reported using the LAM_CAM superclade 
as the baseline. A total of 32 SNPs had an LRT p-value less than 1 x 10-6 (Table 12). Standard 
errors for the odds ratios are shown in Figure 30. 
 
 
Figure 30: Standard errors of odds ratios calculated for each superclade against the 
reference LAM superclade for the Ghanaian cohort 
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Table 12: Top 32 SNPs identified by MLR to be associated with different M. tb superclades in the Ghanaian cohort 
Chr SNP ID Reference 
allele 
Risk 
allele 
OR_LAMCAM 
(Reference) 
BeijingCAS 
OR 
(95%CI) 
EAI_afri 
OR 
(95%CI) 
Ghana2 
OR 
(95%CI) 
OR_HaarlemX 
OR 
(95%CI) 
OR_TU 
OR 
(95%CI) 
LRT 
p-value 
6 rs529920 A G 1 0.4  
(0.22-0.7) 
0.69  
(0.57-0.84) 
1.04  
(0.6-1.8) 
1.1  
(0.84-1.44) 
1.24  
(0.98-1.56) 
1.86e-07 
12 rs73418916 A G 1 0.3 
(0.11-0.81) 
34.15  
(20-58.33) 
1.38  
(0.64-2.96) 
0.76  
(0.51-1.12) 
0.88  
(0.63-1.22) 
2.31e-97 
12 rs138396290 T C 1 0.32  
(0.13-0.77) 
4.59  
(3.63-5.82) 
1.31  
(0.73-2.37) 
0.87  
(0.63-1.19) 
0.91  
(0.7-1.19) 
3.32e-62 
12 rs75717431 T C 1 2.46  
(1.4-4.35) 
0.98  
(0.78-1.24) 
3.3  
(1.88-5.82) 
0.95  
(0.69-1.31) 
0.59  
(0.44-0.8) 
8.55e-09 
12 rs77428482 G A 1 2.56  
(1.45-4.52) 
1.01  
(0.81-1.28) 
3.2  
(1.81-5.64) 
0.95  
(0.69-1.32) 
0.6  
(0.45-0.81) 
1.93e-08 
12 rs77562721 G A 1 2.5  
(1.42-4.41) 
1.04  
(0.82-1.3) 
3.12  
(1.77-5.5) 
0.93  
(0.68-1.29) 
0.6  
(0.45-0.81) 
2.53e-08 
12 rs41524146 C G 1 2.38  
(1.36-4.18) 
1  
(0.8-1.26) 
3.19  
(1.82-5.58) 
0.97  
(0.71-1.34) 
0.61  
(0.45-0.81) 
2.62e-08 
12 rs7299395 G A 1 2.16  
(1.22-3.82) 
0.99  
(0.8-1.24) 
3.12  
(1.77-5.52) 
0.93  
(0.69-1.27) 
0.64  
(0.48-0.84) 
2.50e-07 
12 rs74550821 G A 1 2.59  
(1.47-4.57) 
1.05  
(0.84-1.32) 
3.2  
(1.82-5.63) 
1.01  
(0.74-1.39) 
0.63  
(0.47-0.84) 
2.89e-08 
12 rs144335343 C T 1 2.33  1.08  3.63  1  0.69  9.15e-08 
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(1.32-4.11) (0.87-1.35) (2.05-6.41) (0.73-1.36) (0.52-0.92) 
12 rs6582329 A T 1 2.58  
(1.46-4.57) 
1.07  
(0.85-1.34) 
3.42  
(1.94-6.02) 
1.04  
(0.76-1.43) 
0.67  
(0.5-0.9) 
6.00e-08 
12 rs12296167 T G 1 2.42  
(1.25-4.7) 
2.03  
(1.6-2.59) 
3.33  
(1.71-6.48) 
1.03  
(0.74-1.42) 
1.41  
(1.07-1.85) 
2.02e-09 
12 rs544003050 A G 1 0.5  
(0.24-1.05) 
4.72  
(3.47-6.43) 
1.42  
(0.68-2.98) 
0.75  
(0.52-1.07) 
0.74  
(0.54-1) 
4.17e-40 
12 rs58262822 C G 1 0.58  
(0.34-0.99) 
8.5  
(6.29-11.48) 
0.75  
(0.47-1.2) 
0.81  
(0.65-1.01) 
0.93  
(0.78-1.11) 
1.96e-124 
12 rs11108508 T C 1 1.09  
(0.56-2.09) 
6.61  
(5.26-8.32) 
1.33  
(0.73-2.44) 
0.71  
(0.48-1.05) 
1.11  
(0.85-1.46) 
1.04e-112 
12 rs41472447 A G 1 2.56  
(1.48-4.41) 
0.97  
(0.78-1.21) 
2.94  
(1.71-5.08) 
0.92  
(0.68-1.26) 
0.59  
(0.44-0.79) 
5.70e-09 
13 rs549053537 A T 1 0.63  
(0.41-0.96) 
5.51  
(4.12-7.39) 
1.23  
(0.83-1.82) 
0.86  
(0.71-1.04) 
0.91  
(0.78-1.07) 
8.12e-79 
13 rs73497904 C G 1 1.34  
(0.69-2.59) 
65.39 
(40.67-
105.13) 
1.2  
(0.6-2.39) 
0.96  
(0.67-1.39) 
1.23  
(0.92-1.65) 
2.23e-244 
13 rs9524738 G C 1 1.88  
(0.86-4.14) 
0.31  
(0.26-0.38) 
1.32  
(0.68-2.55) 
1.34  
(0.97-1.84) 
1.16  
(0.9-1.5) 
2.67e-52 
15 rs551641937 G A 1 0.52  
(0.07-3.97) 
275.89 
(152.64-
498.69) 
0.52  
(0.07-3.98) 
0.39  
(0.14-1.14) 
1.11  
(0.59-2.08) 
3.61e-236 
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15 rs35799802 C T 1 0.76  
(0.36-1.62) 
3.08  
(2.29-4.13) 
0.89  
(0.42-1.88) 
1.09  
(0.75-1.59) 
1.19  
(0.87-1.64) 
3.94e-15 
15 rs55747528 C T 1 0.53  
(0.24-1.15) 
28.58 
(15.28-
53.45) 
1.47  
(0.66-3.25) 
0.72  
(0.49-1.05) 
0.79  
(0.57-1.08) 
1.49e-69 
16 rs577800201 C T 1 0.31  
(0.07-1.33) 
93.05 
(54.17-
159.85) 
0.87  
(0.32-2.36) 
0.67  
(0.4-1.13) 
1.01  
(0.68-1.5) 
1.20e-167 
16 rs187181146 C T 1 0.64  
(0.35-1.17) 
8.65  
(6.61-11.31) 
0.94  
(0.59-1.49) 
0.83  
(0.66-1.06) 
0.92  
(0.76-1.12) 
9.77e-152 
16 rs35868343 G A 1 0.72  
(0.46-1.11) 
10.65  
(7.14-15.87) 
1.01  
(0.66-1.55) 
0.91  
(0.74-1.12) 
0.92  
(0.77-1.1) 
1.90e-93 
17 rs143309838 G A 1 0.57  
(0.28-1.17) 
9.38  
(7.2-12.23) 
0.93  
(0.57-1.53) 
0.84  
(0.65-1.08) 
0.99  
(0.81-1.21) 
2.08e-165 
17 rs144224512 C G 1 0.36  
(0.05-2.69) 
220.49 
(118.29-
411.01) 
0.5  
(0.08-3.13) 
0.42  
(0.17-1.01) 
0.74  
(0.4-1.36) 
1.21e-215 
17 rs374315920 C T 1 3.52  
(0.94-13.13) 
548.96 
(270.65-
1113.45) 
1.11  
(0.14-8.79) 
0.85  
(0.27-2.63) 
0.93  
(0.37-2.36) 
1.68e-255 
17 rs77139740 A G 1 0.34  
(0.12-1.01) 
44.94 
(26.85-75.2) 
0.97  
(0.43-2.22) 
0.73  
(0.48-1.12) 
0.89  
(0.63-1.26) 
3.74e-120 
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17 rs77641928 G A 1 1.24  
(0.37-4.17) 
57.29 
(33.69-
97.42) 
0.46  
(0.06-3.62) 
0.67  
(0.3-1.49) 
0.94  
(0.53-1.67) 
4.98e-282 
22 rs553728019 A C 1 0.51  
(0.23-1.09) 
23.66  
(12.1-46.25) 
1.05  
(0.47-2.33) 
0.76  
(0.52-1.11) 
0.79  
(0.57-1.09) 
2.83e-55 
22 rs60153275 C T 1 0.93  
(0.32-2.71) 
61.01 
(36.66-
101.54) 
0.93  
(0.32-2.71) 
0.7  
(0.38-1.28) 
0.98  
(0.63-1.51) 
7.19e-281 
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 Gene annotations of selected SNPs 
4.5.4.1. SAC cohort 
The VEP tool was used to retrieve gene annotations for SNPs of interest. While these SNPs are 
unlikely to have a direct effect on the gene expression itself, the SNP may be in LD with other 
nearby SNPs which do have a direct effect on the gene. For the SAC cohort, the most 
significantly associated SNP was rs9389610 (g.139039029G>A), located on chromosome 6. 
This SNP is an imputed SNP and its two closest directly genotyped SNPs were rs4896385 
(g.139011266G>T), and rs7742202 (g.139074280A>G). The rs4896385 SNP located in 
NHSL-1, while the rs7742202 SNP is located in GVQW2. Neither of these genes have been 
previously shown to be involved in the pathogenesis of TB. The four SNPs located on 
chromosome 5 (Table 11) were annotated to the StAR Related Lipid Transfer Domain 
Containing 4 gene (STARD4) using the VEP tool, while the six SNPs located on chromosome 
17 were annotated to the TANC2 gene. 
 
4.5.4.2. Ghanaian cohort 
Given the prevalence of TB caused by M. africanum strains in West-African countries, 
including Ghana, the most significant results for this cohort were that of several SNPs located 
on chromosomes 15, 16, and 17. The risk allele of one SNP located on chromosome 15, 
rs551641937 (g.62385889G>A), was determined by the MLR to increase the risk of TB caused 
by the EAI/AFRI superclade by 276 times, when compared to the LAMCAM reference 
superclade. The VEP tool, however, did not have any gene annotation listed for this SNP in the 
database. 
 
The risk allele of the SNP rs577800201 (g.20476046C>T) was shown to increase the risk of 
being infected with the EAI/AFRI superclade by 93 times, compared to the LAMCAM 
superclade, and was annotated by the VEP to map to ACSM2A. Lastly, the risk allele of SNP 
rs374315920 (g.38496435C>T) located on chromosome 17, was found to increase an 
individual’s risk of being infected with the EAI/AFRI superclade by more than 500 times, as 
compared to the LAMCAM reference superclade, and the MLR specific for this SNP was 
highly significant with an LRT p-value of 1.68x10-255. This SNP was also annotated by the 
VEP to lie within the retinoic acid receptor alpha (RARA) gene. 
Stellenbosch University  https://scholar.sun.ac.za
   
 
 
 
97 
CHAPTER FIVE 
5. DISCUSSION 
5.1. Overview 
TB is a highly infectious disease affecting millions of people each year. The genetic 
susceptibility of the host to develop the disease has been extensively studied using a number 
of study designs, including linkage analysis, candidate gene, and GWAS. Furthermore, a 
number of selected genes have been investigated for their contribution to genetic susceptibility 
of the host to different strains of M. tb. To date, no workflow has been established to perform 
a genome-wide scan of genetic markers affecting susceptibility to different M. tb strains. 
 
The aim of the present study was to use one cohort to develop a bioinformatics workflow which 
facilitates a test for association of genome-wide SNP markers to multiple strains causing TB. 
Once established, a second cohort was used to independently verify the method developed. The 
study included host genotype and pathogen isolate data from two ethnically distinct cohorts 
and using several reference panels, imputation was performed to obtain a significantly larger 
number of genotypes than previously available in the raw genotype dataset. 
 
After imputation of the study dataset, imputation quality was assessed using marker density, 
and quality score in MAF categories as indicators. Following the selection of the study dataset 
that had been imputed with the highest accuracy, an association analysis between the host 
genotypes and the infecting M. tb superclade was performed using the MLR functionality 
available within SNPTEST. 
 
The MLR functionality within SNPTEST enabled the genome-wide investigation of genetic 
markers for association to a number of M. tb superclades which were defined by clustering of 
clades using a SNP-based phylogenetic tree. Results showed that none of the genotype-M. tb 
relationships passed the GWAS p-value cut-off of 5 x 10-8 for the SAC cohort. For the 
Ghanaian cohort however, 32 SNPs passed the GWAS cut-off and may be considered as 
potential targets for further investigation of HDTs suitable for individuals of West-African 
ancestry. 
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5.2. Review of the method 
 Paired sample collection and SNP genotyping 
The foundation of the association analysis method developed in this study lies in the 
significance of paired sample collection. As with a standard case-control GWAS in which 
genetic associations to a disease are evaluated, whole blood was necessary for the extraction 
of sufficient volumes of DNA from which genotypes of common SNPs could be derived. In 
addition to whole blood, the collection of sputum from the same participants provided the 
necessary bacterial samples for the determination of the infecting M. tb isolate. The blood and 
sputum samples were collected as part of separate studies, and data were archived for future 
analyses. In the present study, two independently collected, yet biologically related, datasets 
were brought together in a novel way to explore the relationship between the affected human 
host and the pathogenic bacterium, for two geographically distinct cohorts.  
 
For the SAC cohort, we had access to an extensive database of M. tb isolates. Of the 527 
genotyped participants with M. tb isolate information, 68 individuals had records for multiple 
infections. While it is possible for participants to have been sampled multiple times throughout 
the recruitment period, we acknowledge that a number of confounding factors may have 
affected the correct sequential representation of an M. tb infection: participants may have gone 
to different clinics during the sample collection period, or may simply have failed to return to 
the clinic. Thus, subsequent M. tb infections may have been incorrectly represented with 
regards to the true order of events or may not have been recorded at all. In light of this, the 
decision to only analyse the ‘first recorded infection’ available for each patient in the cohort 
was taken, and may have minimised the confounding effect of these uncontrollable events. 
 
 Imputation performance 
The more admixed a population is, the greater the heterogeneity in their haplotype block 
structure. This genetic complexity requires large reference panels with suitable ancestry to 
facilitate accurate genotype imputation. While several reference panels exist to facilitate 
genotype imputation, most of these panels focussed on representing populations of European 
ancestry, and little representation was made for African populations. Therefore, the present 
study focussed on evaluating the quality of imputation attainable for the five-way admixed 
SAC population and the Ghanaian cohort using the 1000GP3, AGR, and CAAPA reference 
panels.  
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The five-way admixed SAC population contains genetic contributions from Bantu-speaking 
Africans, Europeans, KhoeSan, and South- and East-Asians (Daya et al. 2013; De Wit et al. 
2010). While imputation has previously been performed on this population, it was done so 
using the 1000 Genomes Phase 1 (The 1000 Genomes Project Consortium 2012) and the 
HapMap3 release 2 (The International HapMap 3 Consortium 2010) reference panels, the latter 
has since been deprecated and in addition, represented mostly individuals of European ancestry 
(Chimusa et al. 2014). To assess recently released reference panels which promised to be of 
greater suitability for the admixed African ancestry of the SAC, we tested the AGR, and the 
CAAPA reference panels, as well as the most recent release of the 1000 Genomes reference 
panel for imputation quality. 
 
Haplotype phasing followed by genotype imputation was carried out using five methods which 
were compared for their imputation quality prior to association analysis (Table 5). Regarding 
ease of use, the Michigan Imputation Server was more user-friendly than the Sanger Imputation 
Server, as the latter required uploading of data via Globus1 and numerous authentications via 
email. However, given that the AGR is not yet publicly available, the SIS is a valuable tool to 
consider for genotype imputation using this reference panel. 
 
The 1000GP3 Version 5 (Sudmant et al. 2015) is publicly accessible, consists of 2 504 samples 
and covers 81 027 987 autosomal markers as well as 3 209 655 markers for the X chromosome. 
Spanning 26 populations across the world, the 1000GP3 offers one of the most diverse 
reference panels to have been compiled to date by including samples sourced from African, 
American, European, South- and East-Asian countries. Continental African populations 
contributing to the reference panel include individuals from the Esan ethnic group in Nigeria, 
Luhya in Kenya, the Yoruban people, as well as participants from The Gambia. Additionally, 
African-American participants were recruited in the United States and Barbados. The 1000GP3 
panel was used for genotype imputation in the IH, MIS, and SIS methods used in this study. 
 
The AGR is comprised of 4 956 samples and covers 93 421 145 sites across the autosomes and 
3 583 058 sites on the X chromosome. Approximately half of the resource is comprised of 
samples from the 1000GP3, while around 2 000 samples were sourced from regions in the 
East-African country of Uganda. Around 100 samples were sourced from several regions in 
                                                 
1 https://www.globus.org/globus-connect-server  
Stellenbosch University  https://scholar.sun.ac.za
   
 
 
 
100 
Ethiopia, as well as from Egypt, the Zulu people in South Africa, and the Nama/Khoesan 
people in Namibia. With twice the number of samples, and the addition of a tremendous amount 
of new genetic material of African ancestry, the AGR promised to be the best resource for 
imputing untyped genetic markers in both the SAC and Ghanaian cohorts, when compared to 
the 1000GP3 reference panel.  
 
The CAAPA resource (Mathias et al. 2016) consists of 883 individuals, amounting to 
approximately one third of the samples on the 1000GP3 and just over a fifth of the number of 
samples on the AGR reference panel. The resource includes individuals self-reporting as 
having African ancestry and were recruited from nine cities in the United States, four 
populations in the Caribbean, four in Central- and South America, and two populations 
representing West Africa. In contrast to the 1000GP3 and the AGR reference panels which 
facilitated imputation of the X chromosome, imputation of the X chromosome with the 
CAAPA resource via the Michigan Imputation Server was not possible. 
 
Three of the five workflows performed imputation of the 1000GP3 reference panel, while two 
methods made use of the AGR, or the CAAPA reference panel. The differences between the 
three methods using the 1000GP3 was the imputation software used, as well as additional strict 
QC filters that were imposed on the study dataset by the MIS and SIS methods. For all five 
workflows, SHAPEIT2 was chosen for haplotype phasing to maintain consistency in the 
haplotype phasing software. Although some studies have reported that pre-phasing reduces 
imputation accuracy (Roshyara et al. 2016), it is known to significantly speed up the 
computationally intensive process of genotype imputation (Kanterakis et al. 2015; B. Howie et 
al. 2012). 
 
For the IH method, imputation was performed using the IMPUTE2 software, while the MIS 
uses minimac3, and the SIS uses the PBWT algorithm. IMPUTE2 reports an information 
(INFO) metric while the minimac software and PBWT algorithm produce an Rsq metric. Both 
forms of quality metrices range from 0 to 1 with higher values indicating better imputation 
qualities.  
 
Our results show that the SAC dataset was imputed with the highest quality using the AGR and 
this outcome was only a slight improvement on the imputation of the 1000GP3 using the IH 
method (Figure 27). In contrast to the results obtained using the AGR, imputation of either the 
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1000GP3 or the CAAPA panels performed by the MIS had the lowest imputation quality scores 
for the SAC.  
 
Where the SIS tool with AGR reached a median quality score of 0.93 for SNPs with an MAF 
ranging between 40 and 50% (Figure 27 A), the MIS only managed to impute the CAAPA and 
1000GP3 to a median quality score of 0.69 and 0.79, respectively. Although the cut-off for 
imputation quality ranges from a score of 0.3 to 0.5, the trend of having lower quality scores 
across the MAF bins further emphasises the selection of the dataset imputed with the highest 
quality, which was the dataset imputed with the AGR. The MIS also performed significantly 
worse than the other tools when imputing rare SNPs with an MAF below 5%, as the median 
quality score obtained did not even reach 0.1 which is far lower than the chosen cut-off of 0.45. 
This was likely in part due to the CAAPA reference panel being the most inappropriate resource 
for imputation of the admixed SAC as the individuals contained on the panel are of African 
ancestry but reside in cities in the United States of America (Mathias et al. 2016), and thus may 
have recent admixture from American ancestors. Unlike the CAAPA resource, both the 
1000GP3 and the AGR contain haplotypes of individuals from continental African countries 
and were therefore better representatives for the ancestry proportions present in the SAC 
population, making either of these two reference panels better than the CAAPA resource for 
imputation of the SAC cohort.  
 
The difference in imputation quality between the IH-1000GP3 and MIS-1000GP3 methods 
may have also been as a result of the imputation tool used, as SHAPEIT was used in both 
methods for haplotype phasing, and the same version of the 1000GP3 reference panel was used. 
Thus, it is possible that the imputation tool, which differed in the two methods, influenced the 
imputation quality achieved, although a recent simulation study has reported similar accuracies 
for imputation of common variants using a range of reference panels and comparing the 
performance of minimac3, IMPUTE2 and Beagle 4.1 (Das et al. 2016). A comparison of the 
three most commonly used imputation tools, minimac, BEAGLE and IMPUTE2, found that 
minimac and IMPUTE2 outperformed usage with BEAGLE (Liu et al. 2015). Another study 
found that minimac3, which is based on the same mathematical formula as minimac, performed 
only slightly better than IMPUTE2 (Das et al. 2016). 
 
When evaluating the Ghanaian cohort, we found that although imputation of the 1000GP3 
reference panel with the IH method performed the best, there was very little difference in the 
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median quality scores for the different workflows seen for SNPs with an MAF of 10-50% 
(Figure 28). For rare variants (MAF 0-5%) however, the IH method outperformed all others 
with a median quality score above 0.75, whereas both analyses with the MIS produced a median 
score below the cut-off of 0.45. Thus, for the Ghanaian cohort, all reference panels and methods 
tested could be considered viable options for imputing common variants with an MAF of 10-
50%, but should be considered carefully for variants with an MAF below 10%.  
 
In contrast to the AGR which contains no individuals recruited from West-African countries, 
the CAAPA resource contains 88 individuals recruited from the West-African country of 
Nigeria (Mathias et al. 2016). We found that the CAAPA resource performed well when 
imputing SNPs with a MAF above 10% (). From an MAF of 20-50%, the CAAPA resource 
performed similarly to the other four resources and may thus be considered suitable for 
imputing cohorts of West-African ancestry, such as the Ghanaian cohort used in this study 
(Figure 28). 
 
 Multinomial Logistic Regression 
To explore the relationship between the genetics of the host and the infecting bacterium, we 
used a logistic regression modelling approach. To make use of the MLR function in SNPTEST, 
it was necessary to define the reference superclade against which beta values for each other 
superclade would be calculated. For this method, the LAM superclade was selected as the 
reference due to it having an intermediate to high frequency in both cohorts (Figure 16 A and 
Figure 19 A). 
 
 SNP-based phylogenetic clustering of M. tb clades 
To reduce the number of phenotype groups of low frequencies being tested in the multinomial 
logistic regression, the many M. tb strains were clustered into “clades” and furthermore into 
“superclades”. For a logistic regression, it is generally recommended that a minimum of ten 
samples be included per group (in this case, superclade) being tested for association. In this 
study, superclades which did not have the minimum of ten samples were excluded, and this 
exclusion was only necessary for the SAC cohort. 
 
For the SAC cohort, eight clades were reduced to five superclades (Figure 8 and Figure 9), and 
for the Ghanaian cohort, 12 clades were grouped into six superclades (Figure 12 and Figure 
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13). For the SAC cohort, there was an unbalanced contribution of Beijing and CAS1 when 
grouping as BeijingCAS1 (Figure 8). Although the Haarlem and HaarlemLike frequencies 
were noticeably different, their biological similarity (Figure 2) may have compensated for this 
difference, and was subsequently grouped with LCC which occurred at a similar frequency to 
Haarlem (Figure 9). The LAM, Other, and Quebec clades were reclassified as superclades after 
clustering, with the latter two superclades having the lowest frequencies (n=60 and n=40, 
respectively) in the SAC cohort. Furthermore, prior to grouping into superclades, the clade 
distribution of the selected samples included in this study correlated with the distribution 
described in the most recent epidemiological study performed on the same population and thus 
demonstrated that the SAC study cohort included in the association analysis was a suitable 
representation of the strain distribution seen at the time of sample collection (van der Spuy et 
al. 2009). 
 
For the Ghanaian cohort, only one of the 12 clades - the U clade - had a frequency of below 10 
(Figure 12), and was clustered with the T clade (Figure 13) which had a significantly larger 
number of cases (n=235). A largely unbalanced frequency was also observed when clustering 
LAM and CAM cases, with the latter clade having a frequency 13 times more than LAM. This 
was also seen when clustering the two M. africanum clades, “afri181” and “afri438”, with EAI 
(Figure 13). The frequency of the Haarlem clade was twice as large as the X clade, while the 
Beijing and CAS clades had a similar frequency prior to grouping (Figure 12). This grouping 
strategy, and the frequencies of the contributing clades need to be carefully considered when 
interpreting the odds ratios obtained from the multinomial logistic regression, as they may 
inflate the effect predicted for the smaller contributing clade. 
 
The genome-wide significance cut-off of 5 x 10-8 is the widely accepted threshold for GWAS 
studies and aims to prevent inflating the occurrence of type I errors on a genome-wide scale 
(Durbin 2014). Unless the sample size is large enough to obtain sufficient power for the 
phenotype being tested, this very low threshold reduces the probability of correctly identifying 
SNPs having a small effect size (Stringer et al. 2011). When assessing the standard errors of 
the odds ratios obtained for the MLR, we found that the smallest superclades in both cohorts 
had the largest variation in their standard errors (Figure 29 and Figure 30). This further 
demonstrated the need for sufficient sample sizes in each phenotype (superclade) being tested 
for genetic associations, as well as justifying the clustering of clades into superclades. 
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 Human genome-wide associations with M. tb superclades 
Although none of the SNPs passed the GWAS p-value cut-off of 5 x 10-8 in the SAC cohort, 
the most significant associations are reported in Table 11. It is likely due to the small sample 
size, with a subsequent reduction in statistical power, that none of the SNPs passed the p-value 
cut-off for the SAC cohort. In contrast, 30 SNPs were reported to be significantly associated 
with the superclade phenotypes tested for the Ghanaian cohort (Table 12). None of the SNPs 
with an LRT p-value less than 0.0005 in either cohort were found in the other, demonstrating 
the potentially population-specific association of SNPs with the different M. tb superclades, 
which has been previously shown in the investigation of TLRs and their association with cases 
of TB in populations of different ethnicities (Schurz et al. 2015). 
 
For the Ghanaian cohort, 30 SNPs with significant LRT p-values for their MLRs were 
identified as being associated with the M. tb superclades investigated (Table 12). Nine of the 
SNPs located on chromosome 12 were mapped to PDZRN4. For these nine SNPs, the risk allele 
increased the chances of individuals being infected with the BeijingCAS superclades 2.5 times, 
and in the region of 3 times for the Ghana2 superclade, while the risk allele halved the chances 
of being infected with the TU superclade. Due to the low frequencies of the BeijingCAS and 
Ghana2 superclades observed for this cohort (Figure 13), it is possible that these odds ratios 
had been inflated by small sample sizes. Thus, the best interpretation for this cohort is that 
individuals with the risk alleles for these SNPs were at equal risk for having TB caused by the 
LAMCAM, EAI/AFRI, and HaarlemX superclades. 
 
Sparse literature exists describing the direct influence of M. tb infection on the STARD4 and 
RARA genes, and no studies have investigated the outcomes of infection with different M. tb 
strains on these genes. The literature currently available are described in the paragraphs to 
follow. 
 
5.2.5.1. STARD4  
Cholesterol is essential for the maintenance of mammalian cell walls, and is a precursor for 
vitamin D, bile acids, and steroid hormones (Reviewed in Cruz et al. 2013). While cholesterol 
can be produced endogenously from acetate, the presence of excess concentrations of low 
density lipoprotein (LDL) cholesterol is known to be a serious health risk (Colpo 2005). The 
STARD4 gene encodes the StAR-related lipid transfer protein which plays a crucial role in the 
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transmembrane trafficking of lipids (such as cholesterol) - an important energy source (Soccio 
et al. 2002). 
 
Differential transcriptional responses have been observed when mouse bone marrow derived 
macrophages were infected with two strains of M. tb. Infection with the HN878 strain was 
reported to have upregulated more host genes involved in lipid metabolism including the 
STARD4 gene, than infection with CDC1551 (Koo et al. 2012). The H37Rv M. tb strain 
reportedly induced a significantly upregulated expression of 386 genes in response to a 
lipid-rich environment, with those genes being implicated in efflux systems, sulphur reduction 
processes, and the capturing of iron (Aguilar-Ayala et al. 2017).  
 
Infection of macrophages with pathogens such as M. tb stimulates the process of lipid droplet 
formation (Daniel et al. 2011). It has been hypothesised that M. tb initiates this process in an 
attempt to secure a reliable source of carbon to fuel bacterial growth (Brzostek et al. 2009). In 
addition to lipids being an energy source, the accumulation of cholesterol in the bacterial cell 
wall was shown to drastically reduce the permeability of the cell wall, subsequently reducing 
the penetrating capability of the anti-TB drug RIF (Brzostek et al. 2009). However, a recent 
study has contradicted the notion that lipid droplet formation is a bacteria-driven process. 
Instead, it was proposed that the formation of lipids is an immune system-activated process, 
and does not occur as a result of direct stimulation by M. tb, but rather via the IFN-, 
H1F--dependent pathway of the host immune system (Knight et al. 2018).  
 
5.2.5.2. RARA 
All-trans retinoic acid, the active form of Vitamin A, plays an essential role in the normal 
functioning of the adaptive and innate immune systems. The oral administration of retinoic 
acid to rats resulted in inhibition of the M. tb growth, following in vitro infection (Yamada et 
al. 2007).  
 
The results of this study have highlighted several SNPs which possibly significantly increased 
the risk of individuals with Ghanaian ethnicity to being infected with the endemic TB strain of 
M. africanum. Given the burden of disease, and the dominance of M. africanum strains in 
Ghana, it may be a worthwhile expedition to explore the functional effect of these SNPs on the 
biological processes described. 
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5.3. Method validation in secondary cohort 
The SAC cohort used to develop the method provided a platform of numerous challenges, 
enabling a thorough examination of the data and potential problems which may be encountered 
in other datasets. These challenges including dealing with missing data, incorrect infection 
assignments, and multiple infections. The SAC cohort is also a highly admixed population, not 
adequately represented in most of the currently publicly available reference panels. This degree 
of admixture provided another challenge which enabled the investigation of the suitability of 
different reference panels for imputation in the study dataset. Once the study cohort could be 
determined as having being imputed with a high quality, it was deemed sufficient for the 
association test using multinomial logistic regression. Although sample size likely impeded 
our statistical power to determine significant genome-wide associations to M. tb strains in the 
SAC dataset, we were able to demonstrate the use of the method and obtain SNPs near GWAS 
significance. 
 
Replication of the method in the Ghanaian dataset was remarkably easier as only one infection 
was recorded in the database provided, with no missing data, making the Strain database QC 
easier in this dataset than in the SAC dataset. Furthermore, the principal components provided 
for the cohort to account for differences in ethnic contributions showed that the Ghanaian 
cohort was significantly less admixed than the SAC cohort. Individuals from West-Africa are 
also well-represented in the 1000GP3 and thus, it was not surprising that the 1000GP3 
reference panel provided the highest quality of imputed genotype data. 
 
Where whole-genome sequencing is not possible due to cost, genotype imputation of 
haplotypes from reference panels is a valuable solution to inferring untyped SNP markers to 
be used in GWAS. The use of the MIS and SIS aided the development of this method 
tremendously as the computational burden is split between an in-house server and two off-site 
servers. Both off-site servers are publicly accessible and require no payment for imputation 
service, making it a feasible option for resource-restricted institutions and research groups. 
 
5.4. Limitations of the method  
Obtaining a suitable sample size is a problem inherent of GWA studies making use of logistic 
regression modelling. Furthermore, the many phenotypes being analysed in this study, 
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demanded a sufficient number of cases for each class. The frequency of each M. tb clade 
however, is dependent not only on the host, but is also affected by the virulence of the 
bacterium. Thus, with all these considered, the sample sizes included in the MLR should be 
sufficient for inclusion in the analysis but will likely also reflect the distribution in the 
population. 
 
Another limitation of the study is that at the time of analysis, the AGR reference panel was not 
publicly available for download to a local machine. Thus, its use in this study could only be 
facilitated via the SIS, a freely accessible online imputation server. Through this, we were able 
to obtain high-quality imputed data for the SAC, but it was necessary to be mindful when 
drawing comparisons as the other workflows made use of different imputation software. 
 
5.5. Recommendations for future studies 
This study would not have been possible were it not for the collection of paired samples of 
blood and sputum from study participants. Thus, future studies will require that both samples 
be collected from participants in order to perform this association analysis. In order to prevent 
the reduction in statistical power of the association test, we chose to exclude low frequency 
M. tb cases at the superclade level. However, this may have brought in a weakness in 
interpretation of the odds ratios derived from the model. Therefore, in further applications of 
this method, it may be advisable to exclude low frequency clades prior to clustering, as opposed 
to the superclades used in this study. Lastly, Bayesian analysis of this data should be explored 
as it allows for the inclusion of priors such as strain prevalence which could not be included 
using the current method. Future studies may also assess imputation accuracy obtained from 
other combinations of software and reference panels, such as the AGR when it becomes 
publicly available, along with the IMPUTE2 software. The candidate genes identified in both 
cohorts might also be explored as possible targets for HDTs. 
 
5.6. Concluding remarks 
The main output of this study is the method developed which facilitates the association analysis 
of genome-wide SNP markers to the M. tb clades causing disease in humans. From the study 
we were able to identify the AGR as the best resource for imputing the admixed SAC 
population, as well as the 1000GP3 as the best resource for imputing cohorts of West-African 
ancestry. In contrast to another study that aimed to perform a genome-wide association analysis 
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with Beijing- and non-Beijing M. tb clades, we developed a method that could assess the 
potential associations between SNPs and more than two phenotype classes. Furthermore, the 
SNPs obtained from the MLR showed that with a large cohort (as in the Ghanaian cohort), we 
were able to identify SNPs with highly significant LRT p-values for association to M. tb 
superclade. 
 
With the current trajectory of the TB epidemic, novel methods are needed to augment current 
anti-TB therapies and combat the disease. This study provides the groundwork for future 
genome-wide association studies wishing to investigate the relationship between the host and 
the many strains of M. tb causing disease. Furthermore, the SNPs identified in this study may 
be evaluated in functional studies to assess their viability as targets for host-directed therapies. 
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7. Appendix I: Extended M. tb clade and superclade distributions in the 
SAC cohort having multiple infection records 
7.1. Distributions of Clades and Superclades for One and Two infection 
participants in the SAC cohort 
 
Stellenbosch University  https://scholar.sun.ac.za
   
 
 
 
126 
 
 
Figure 31: Frequency distributions for records of participants having one infection (n = 459) and the two infections (120 records for 60 
participants) in the SAC cohort matched to M. tb clade. Figures A and B show the distribution for participants with one infection while figures C 
and D show the distribution for participants having two infections. 
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Figure 32: Frequency distributions for records for each of the infections listed for the genotyped participants having two infections recorded in 
the database. Figures A and B show the clade- and superclade distributions for the first infection, while figures C and D show the clade and 
superclade distributions for the second of the two infections. 
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